JP2013532692A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013532692A5 JP2013532692A5 JP2013522013A JP2013522013A JP2013532692A5 JP 2013532692 A5 JP2013532692 A5 JP 2013532692A5 JP 2013522013 A JP2013522013 A JP 2013522013A JP 2013522013 A JP2013522013 A JP 2013522013A JP 2013532692 A5 JP2013532692 A5 JP 2013532692A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- carbonyl
- piperidin
- piperidine
- picolinamide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000000217 alkyl group Chemical group 0.000 claims description 252
- 150000001875 compounds Chemical class 0.000 claims description 134
- -1 methoxy, ethoxy Chemical group 0.000 claims description 100
- 150000003839 salts Chemical class 0.000 claims description 50
- 239000012453 solvate Substances 0.000 claims description 43
- 150000001204 N-oxides Chemical class 0.000 claims description 42
- 229910052799 carbon Inorganic materials 0.000 claims description 23
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 23
- 125000004122 cyclic group Chemical group 0.000 claims description 22
- 125000001188 haloalkyl group Chemical group 0.000 claims description 22
- 229910052736 halogen Inorganic materials 0.000 claims description 21
- 229910052757 nitrogen Inorganic materials 0.000 claims description 17
- 201000010099 disease Diseases 0.000 claims description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 14
- 125000001072 heteroaryl group Chemical group 0.000 claims description 14
- 239000008194 pharmaceutical composition Substances 0.000 claims description 11
- 125000005549 heteroarylene group Chemical group 0.000 claims description 9
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 8
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims description 8
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 8
- 125000000732 arylene group Chemical group 0.000 claims description 7
- 208000006011 Stroke Diseases 0.000 claims description 6
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 claims description 5
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 claims description 5
- 229940106189 ceramide Drugs 0.000 claims description 5
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 claims description 5
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- 102000004201 Ceramidases Human genes 0.000 claims description 4
- 108090000751 Ceramidases Proteins 0.000 claims description 4
- 206010013801 Duchenne Muscular Dystrophy Diseases 0.000 claims description 4
- 206010019280 Heart failures Diseases 0.000 claims description 4
- 150000001408 amides Chemical class 0.000 claims description 4
- 125000003118 aryl group Chemical group 0.000 claims description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 4
- 150000002367 halogens Chemical class 0.000 claims description 4
- 208000028867 ischemia Diseases 0.000 claims description 4
- 125000002950 monocyclic group Chemical group 0.000 claims description 4
- 125000006578 monocyclic heterocycloalkyl group Chemical group 0.000 claims description 4
- 206010007559 Cardiac failure congestive Diseases 0.000 claims description 3
- 125000003545 alkoxy group Chemical group 0.000 claims description 3
- 230000002503 metabolic effect Effects 0.000 claims description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- 230000001590 oxidative effect Effects 0.000 claims description 3
- 208000011580 syndromic disease Diseases 0.000 claims description 3
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims description 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 3
- 102100036009 5'-AMP-activated protein kinase catalytic subunit alpha-2 Human genes 0.000 claims description 2
- ISSLZKSSYLRMSG-JDXGNMNLSA-N 5-[(3S,4S)-4-(4-cyanophenoxy)-3-fluoropiperidine-1-carbonyl]-N-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound O([C@H]1CCN(C[C@@H]1F)C(=O)C=1C=NC(=CC=1)C(=O)NC1CCN(CC=2C=CC(=CC=2)C#N)CC1)C1=CC=C(C#N)C=C1 ISSLZKSSYLRMSG-JDXGNMNLSA-N 0.000 claims description 2
- KMRPXMWIZLSCAG-IZZNHLLZSA-N 5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]-n-[(3s,4r)-3-fluoro-1-(pyridin-4-ylmethyl)piperidin-4-yl]pyridine-2-carboxamide Chemical compound C([C@@H]([C@@H](CC1)NC(=O)C=2N=CC(=CC=2)C(=O)N2CCN(CC=3C=CC(F)=CC=3)CC2)F)N1CC1=CC=NC=C1 KMRPXMWIZLSCAG-IZZNHLLZSA-N 0.000 claims description 2
- SSXKELDQHCLBAC-VQTJNVASSA-N 5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]-n-[(3s,4r)-3-fluoropiperidin-4-yl]pyridine-2-carboxamide Chemical compound F[C@H]1CNCC[C@H]1NC(=O)C1=CC=C(C(=O)N2CCN(CC=3C=CC(F)=CC=3)CC2)C=N1 SSXKELDQHCLBAC-VQTJNVASSA-N 0.000 claims description 2
- 206010002383 Angina Pectoris Diseases 0.000 claims description 2
- 201000001320 Atherosclerosis Diseases 0.000 claims description 2
- WSHUFJLKIMPHGV-FQLXRVMXSA-N CC1=CC=C(C=C1)C(=O)C2CCN(CC2)C(=O)C3=CN=C(C=C3)C(=O)N[C@@H]4CCN(C[C@H]4F)CC5=CC=C(C=C5)C#N Chemical compound CC1=CC=C(C=C1)C(=O)C2CCN(CC2)C(=O)C3=CN=C(C=C3)C(=O)N[C@@H]4CCN(C[C@H]4F)CC5=CC=C(C=C5)C#N WSHUFJLKIMPHGV-FQLXRVMXSA-N 0.000 claims description 2
- ODBQSZFTJYTYMN-FQLXRVMXSA-N CC1=CC=C(C=C1)OC2CCN(CC2)C(=O)C3=CN=C(C=C3)C(=O)N[C@@H]4CCN(C[C@H]4F)CC5=CC=C(C=C5)C#N Chemical compound CC1=CC=C(C=C1)OC2CCN(CC2)C(=O)C3=CN=C(C=C3)C(=O)N[C@@H]4CCN(C[C@H]4F)CC5=CC=C(C=C5)C#N ODBQSZFTJYTYMN-FQLXRVMXSA-N 0.000 claims description 2
- 206010008874 Chronic Fatigue Syndrome Diseases 0.000 claims description 2
- 206010012289 Dementia Diseases 0.000 claims description 2
- 229920002527 Glycogen Polymers 0.000 claims description 2
- 101000783681 Homo sapiens 5'-AMP-activated protein kinase catalytic subunit alpha-2 Proteins 0.000 claims description 2
- 206010022562 Intermittent claudication Diseases 0.000 claims description 2
- 208000010428 Muscle Weakness Diseases 0.000 claims description 2
- 206010028372 Muscular weakness Diseases 0.000 claims description 2
- 208000036572 Myoclonic epilepsy Diseases 0.000 claims description 2
- 208000002033 Myoclonus Diseases 0.000 claims description 2
- 206010053648 Vascular occlusion Diseases 0.000 claims description 2
- 230000003213 activating effect Effects 0.000 claims description 2
- 208000008445 altitude sickness Diseases 0.000 claims description 2
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 2
- 239000003085 diluting agent Substances 0.000 claims description 2
- 239000003937 drug carrier Substances 0.000 claims description 2
- 201000009028 early myoclonic encephalopathy Diseases 0.000 claims description 2
- 229930195729 fatty acid Natural products 0.000 claims description 2
- 239000000194 fatty acid Substances 0.000 claims description 2
- 150000004665 fatty acids Chemical class 0.000 claims description 2
- 230000004190 glucose uptake Effects 0.000 claims description 2
- 229940096919 glycogen Drugs 0.000 claims description 2
- 208000021156 intermittent vascular claudication Diseases 0.000 claims description 2
- 208000029766 myalgic encephalomeyelitis/chronic fatigue syndrome Diseases 0.000 claims description 2
- 208000010125 myocardial infarction Diseases 0.000 claims description 2
- XSTWHJANPVSKRP-FQLXRVMXSA-N n-[(3r,4r)-1-[(4-cyano-3-fluorophenyl)methyl]-3-fluoropiperidin-4-yl]-6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)N[C@H]2[C@@H](CN(CC=3C=C(F)C(C#N)=CC=3)CC2)F)CC1 XSTWHJANPVSKRP-FQLXRVMXSA-N 0.000 claims description 2
- BFKLKEDGPVUXEU-VSGBNLITSA-N n-[(3r,4r)-1-[(4-cyanophenyl)methyl]-3-fluoropiperidin-4-yl]-6-[4-[4-(trifluoromethylsulfonyl)phenoxy]piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C([C@H]([C@@H](CC1)NC(=O)C=2C=NC(=CC=2)C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)S(=O)(=O)C(F)(F)F)F)N1CC1=CC=C(C#N)C=C1 BFKLKEDGPVUXEU-VSGBNLITSA-N 0.000 claims description 2
- MWVAIOSVWVODAN-VSGBNLITSA-N n-[(3r,4r)-3-fluoro-1-[[4-(trifluoromethoxy)phenyl]methyl]piperidin-4-yl]-5-[4-(4-methylsulfonylbenzoyl)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(S(=O)(=O)C)=CC=C1C(=O)C1CCN(C(=O)C=2C=NC(=CC=2)C(=O)N[C@H]2[C@@H](CN(CC=3C=CC(OC(F)(F)F)=CC=3)CC2)F)CC1 MWVAIOSVWVODAN-VSGBNLITSA-N 0.000 claims description 2
- QYKFEEHGZRXLOV-VSGBNLITSA-N n-[(3r,4r)-3-fluoro-1-[[4-(trifluoromethoxy)phenyl]methyl]piperidin-4-yl]-5-[4-(4-methylsulfonylphenoxy)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(S(=O)(=O)C)=CC=C1OC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)N[C@H]2[C@@H](CN(CC=3C=CC(OC(F)(F)F)=CC=3)CC2)F)CC1 QYKFEEHGZRXLOV-VSGBNLITSA-N 0.000 claims description 2
- QFCGCJFUXOLOOW-RRPNLBNLSA-N n-[(3s,4r)-1-[(4-chlorophenyl)methyl]-3-fluoropiperidin-4-yl]-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C([C@@H]([C@@H](CC1)NC(=O)C=2N=CC(=CC=2)C(=O)N2CCN(CC=3C=CC(F)=CC=3)CC2)F)N1CC1=CC=C(Cl)C=C1 QFCGCJFUXOLOOW-RRPNLBNLSA-N 0.000 claims description 2
- QECRHJAQOQEILO-IZZNHLLZSA-N n-[(3s,4r)-3-fluoro-1-[(2-methyl-1,3-thiazol-4-yl)methyl]piperidin-4-yl]-6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)N[C@H]2[C@H](CN(CC=3N=C(C)SC=3)CC2)F)CC1 QECRHJAQOQEILO-IZZNHLLZSA-N 0.000 claims description 2
- HJLLFICFQXAIAT-IZZNHLLZSA-N n-[(3s,4r)-3-fluoro-1-[(5-methyl-1,2-oxazol-3-yl)methyl]piperidin-4-yl]-6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)N[C@H]2[C@H](CN(CC3=NOC(C)=C3)CC2)F)CC1 HJLLFICFQXAIAT-IZZNHLLZSA-N 0.000 claims description 2
- LEUSDRGCPVXECX-VMPREFPWSA-N n-[(3s,4s)-1-[(4-cyanophenyl)methyl]-3-fluoropiperidin-4-yl]-6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)N[C@@H]2[C@H](CN(CC=3C=CC(=CC=3)C#N)CC2)F)CC1 LEUSDRGCPVXECX-VMPREFPWSA-N 0.000 claims description 2
- FKPPDDDQZXPHNG-UHFFFAOYSA-N n-[1-[(3-fluoro-4-methoxyphenyl)methyl]piperidin-4-yl]-6-[4-(4-pyrrolidin-1-ylbenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=C(F)C(OC)=CC=C1CN1CCC(NC(=O)C=2C=NC(=CC=2)C(=O)N2CCC(CC2)C(=O)C=2C=CC(=CC=2)N2CCCC2)CC1 FKPPDDDQZXPHNG-UHFFFAOYSA-N 0.000 claims description 2
- 230000008816 organ damage Effects 0.000 claims description 2
- 230000003647 oxidation Effects 0.000 claims description 2
- 238000007254 oxidation reaction Methods 0.000 claims description 2
- 230000037361 pathway Effects 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- 208000024891 symptom Diseases 0.000 claims description 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims description 2
- 208000021331 vascular occlusion disease Diseases 0.000 claims description 2
- 125000004737 (C1-C6) haloalkoxy group Chemical group 0.000 claims 3
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 claims 3
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 claims 2
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 claims 2
- 125000001424 substituent group Chemical group 0.000 claims 2
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims 1
- 208000010444 Acidosis Diseases 0.000 claims 1
- 206010003591 Ataxia Diseases 0.000 claims 1
- 206010048804 Kearns-Sayre syndrome Diseases 0.000 claims 1
- 208000006136 Leigh Disease Diseases 0.000 claims 1
- 208000017507 Leigh syndrome Diseases 0.000 claims 1
- 208000029578 Muscle disease Diseases 0.000 claims 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims 1
- 230000007950 acidosis Effects 0.000 claims 1
- 208000026545 acidosis disease Diseases 0.000 claims 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 1
- 210000004556 brain Anatomy 0.000 claims 1
- 210000004351 coronary vessel Anatomy 0.000 claims 1
- 239000000835 fiber Substances 0.000 claims 1
- 150000004677 hydrates Chemical class 0.000 claims 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- 230000002438 mitochondrial effect Effects 0.000 claims 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 239000001301 oxygen Substances 0.000 claims 1
- 125000006340 pentafluoro ethyl group Chemical group FC(F)(F)C(F)(F)* 0.000 claims 1
- 238000000034 method Methods 0.000 description 50
- 239000000126 substance Substances 0.000 description 45
- 239000000203 mixture Substances 0.000 description 33
- 210000004027 cell Anatomy 0.000 description 16
- 0 C*[C@](C)(*)N=*C Chemical compound C*[C@](C)(*)N=*C 0.000 description 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 5
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 230000036542 oxidative stress Effects 0.000 description 4
- IBBMAWULFFBRKK-UHFFFAOYSA-N picolinamide Chemical compound NC(=O)C1=CC=CC=N1 IBBMAWULFFBRKK-UHFFFAOYSA-N 0.000 description 4
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 208000012902 Nervous system disease Diseases 0.000 description 3
- 125000000753 cycloalkyl group Chemical group 0.000 description 3
- 125000006505 p-cyanobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C#N)C([H])([H])* 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- GJHZOKKWVMPWMH-UHFFFAOYSA-N 2-N-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridine-2,5-dicarboxamide Chemical compound N1=C(C=CC(=C1)C(=O)N)C(=O)NC1CCN(CC1)CC1=CC=C(C=C1)C#N GJHZOKKWVMPWMH-UHFFFAOYSA-N 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- KILULKZXXSWNCI-UHFFFAOYSA-N N-[4-(4-cyanophenoxy)cyclohexyl]-5-[4-(4-fluorobenzoyl)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1C(=O)C1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCC(CC2)OC=2C=CC(=CC=2)C#N)CC1 KILULKZXXSWNCI-UHFFFAOYSA-N 0.000 description 2
- BZCVQNXMJJLXPG-UHFFFAOYSA-N N-[4-(4-cyanophenoxy)cyclohexyl]-5-[4-(4-fluorophenoxy)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1OC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCC(CC2)OC=2C=CC(=CC=2)C#N)CC1 BZCVQNXMJJLXPG-UHFFFAOYSA-N 0.000 description 2
- QVGHVUBOGYEDKB-UHFFFAOYSA-N N-[4-(4-cyanophenoxy)cyclohexyl]-5-[4-(4-methoxyphenoxy)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1OC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCC(CC2)OC=2C=CC(=CC=2)C#N)CC1 QVGHVUBOGYEDKB-UHFFFAOYSA-N 0.000 description 2
- 125000002947 alkylene group Chemical group 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000036571 hydration Effects 0.000 description 2
- 238000006703 hydration reaction Methods 0.000 description 2
- 208000027866 inflammatory disease Diseases 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000004065 mitochondrial dysfunction Effects 0.000 description 2
- 210000001087 myotubule Anatomy 0.000 description 2
- 229960003966 nicotinamide Drugs 0.000 description 2
- 235000005152 nicotinamide Nutrition 0.000 description 2
- 239000011570 nicotinamide Substances 0.000 description 2
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 2
- 230000004137 sphingolipid metabolism Effects 0.000 description 2
- BKCJRBLXKYEYHK-UHFFFAOYSA-N 1-[(4-cyanophenyl)methyl]-n-[5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridin-2-yl]piperidine-4-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(NC(=O)C3CCN(CC=4C=CC(=CC=4)C#N)CC3)=CC=2)CC1 BKCJRBLXKYEYHK-UHFFFAOYSA-N 0.000 description 1
- GFDOYTAWIKLKSA-UHFFFAOYSA-N 2-n,5-n-bis(1-benzylpiperidin-4-yl)pyridine-2,5-dicarboxamide Chemical compound C=1C=C(C(=O)NC2CCN(CC=3C=CC=CC=3)CC2)N=CC=1C(=O)NC(CC1)CCN1CC1=CC=CC=C1 GFDOYTAWIKLKSA-UHFFFAOYSA-N 0.000 description 1
- ZNLOQOLMQYQXNI-UHFFFAOYSA-N 2-n,6-n-bis[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridine-2,6-dicarboxamide Chemical compound C=1C=CC(C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 ZNLOQOLMQYQXNI-UHFFFAOYSA-N 0.000 description 1
- RKTWPHQFWGVWFF-UHFFFAOYSA-N 2-n,6-n-bis[1-[(4-fluorophenyl)methyl]piperidin-4-yl]pyridine-2,6-dicarboxamide Chemical compound C1=CC(F)=CC=C1CN1CCC(NC(=O)C=2N=C(C=CC=2)C(=O)NC2CCN(CC=3C=CC(F)=CC=3)CC2)CC1 RKTWPHQFWGVWFF-UHFFFAOYSA-N 0.000 description 1
- CWIOPRLBOMZPKA-UHFFFAOYSA-N 2-n-(1-benzylpiperidin-4-yl)-5-n-(4-phenylphenyl)pyridine-2,5-dicarboxamide Chemical compound C=1C=C(C(=O)NC2CCN(CC=3C=CC=CC=3)CC2)N=CC=1C(=O)NC(C=C1)=CC=C1C1=CC=CC=C1 CWIOPRLBOMZPKA-UHFFFAOYSA-N 0.000 description 1
- PYLAIZRZOYDMDH-UHFFFAOYSA-N 2-n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-n-[1-(4-cyanophenyl)piperidin-4-yl]pyridine-2,5-dicarboxamide Chemical compound C=1C=C(C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)N=CC=1C(=O)NC(CC1)CCN1C1=CC=C(C#N)C=C1 PYLAIZRZOYDMDH-UHFFFAOYSA-N 0.000 description 1
- DENRPACRNJYZDG-UHFFFAOYSA-N 2-n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-n-[2-(4-fluorophenoxy)ethyl]pyridine-2,5-dicarboxamide Chemical compound C1=CC(F)=CC=C1OCCNC(=O)C1=CC=C(C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)N=C1 DENRPACRNJYZDG-UHFFFAOYSA-N 0.000 description 1
- NAUIMQDUCLBJRJ-UHFFFAOYSA-N 2-n-[2-[(4-cyanophenyl)methyl]-3,4-dihydro-1h-isoquinolin-7-yl]-5-n-[(4-fluorophenyl)methyl]pyridine-2,5-dicarboxamide Chemical compound C1=CC(F)=CC=C1CNC(=O)C1=CC=C(C(=O)NC=2C=C3CN(CC=4C=CC(=CC=4)C#N)CCC3=CC=2)N=C1 NAUIMQDUCLBJRJ-UHFFFAOYSA-N 0.000 description 1
- PTNAVJCDQOQYQW-BXWFABGCSA-N 4-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-N-[2-[2-[2-[2-(3-amino-3-oxopropoxy)ethoxy]ethoxy]ethoxy]ethyl]butanamide Chemical compound NC(=O)CCOCCOCCOCCOCCNC(=O)CCC[C@@H]1SC[C@@H]2NC(=O)N[C@H]12 PTNAVJCDQOQYQW-BXWFABGCSA-N 0.000 description 1
- HJQDYLZIUZAGJL-UHFFFAOYSA-N 4-[(4-fluorophenyl)methyl]piperazine-1-carbaldehyde Chemical compound C1=CC(F)=CC=C1CN1CCN(C=O)CC1 HJQDYLZIUZAGJL-UHFFFAOYSA-N 0.000 description 1
- BWGZBBSRFIGRTF-UHFFFAOYSA-N 4-[1-[5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridin-2-yl]piperidin-4-yl]oxybenzonitrile Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)N2CCC(CC2)OC=2C=CC(=CC=2)C#N)CC1 BWGZBBSRFIGRTF-UHFFFAOYSA-N 0.000 description 1
- OLOFHQKCBQKIAJ-UHFFFAOYSA-N 4-[[2-[5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridin-2-yl]-2,8-diazaspiro[4.5]decan-8-yl]methyl]benzonitrile Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)N2CC3(CC2)CCN(CC=2C=CC(=CC=2)C#N)CC3)CC1 OLOFHQKCBQKIAJ-UHFFFAOYSA-N 0.000 description 1
- AUSCOAAXXZHOLH-UHFFFAOYSA-N 4-[[4-[[5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridin-2-yl]amino]piperidin-1-yl]methyl]benzonitrile Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(NC3CCN(CC=4C=CC(=CC=4)C#N)CC3)=CC=2)CC1 AUSCOAAXXZHOLH-UHFFFAOYSA-N 0.000 description 1
- GUOFMHPMAHVMLC-UHFFFAOYSA-N 4-[[8-[5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carbonyl]-2,8-diazaspiro[4.5]decan-2-yl]methyl]benzonitrile Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)N2CCC3(CN(CC=4C=CC(=CC=4)C#N)CC3)CC2)CC1 GUOFMHPMAHVMLC-UHFFFAOYSA-N 0.000 description 1
- UZKLXKCSYXORTD-UHFFFAOYSA-N 5-(4-benzoylpiperazine-1-carbonyl)-n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound C=1C=C(C(=O)N2CCN(CC2)C(=O)C=2C=CC=CC=2)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 UZKLXKCSYXORTD-UHFFFAOYSA-N 0.000 description 1
- ZTXYRALKNNXSHH-UHFFFAOYSA-N 5-(4-benzylanilino)-n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound C=1C=C(NC=2C=CC(CC=3C=CC=CC=3)=CC=2)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 ZTXYRALKNNXSHH-UHFFFAOYSA-N 0.000 description 1
- TUXSVDQMBSARPI-UHFFFAOYSA-N 5-(4-benzylpiperazin-1-yl)-n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound C=1C=C(N2CCN(CC=3C=CC=CC=3)CC2)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 TUXSVDQMBSARPI-UHFFFAOYSA-N 0.000 description 1
- OQMKCTWXRSKXFX-UHFFFAOYSA-N 5-(4-benzylpiperazine-1-carbonyl)-n-(1-benzylpiperidin-4-yl)pyridine-2-carboxamide Chemical compound C=1C=C(C(=O)N2CCN(CC=3C=CC=CC=3)CC2)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=CC=C1 OQMKCTWXRSKXFX-UHFFFAOYSA-N 0.000 description 1
- UHPFGVZAKOCMFD-UHFFFAOYSA-N 5-(4-benzylpiperidine-1-carbonyl)-n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound C=1C=C(C(=O)N2CCC(CC=3C=CC=CC=3)CC2)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 UHPFGVZAKOCMFD-UHFFFAOYSA-N 0.000 description 1
- JZOSWLKELUSKPW-SANMLTNESA-N 5-[(3s)-3-(4-fluorophenoxy)pyrrolidine-1-carbonyl]-n-[1-[(4-fluorophenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCC(NC(=O)C=2N=CC(=CC=2)C(=O)N2C[C@H](CC2)OC=2C=CC(F)=CC=2)CC1 JZOSWLKELUSKPW-SANMLTNESA-N 0.000 description 1
- HVGKNJVYYFTFOB-UHFFFAOYSA-N 5-[3-(4-cyanophenoxy)-8-azabicyclo[3.2.1]octane-8-carbonyl]-n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound C=1C=C(C(=O)N2C3CCC2CC(C3)OC=2C=CC(=CC=2)C#N)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 HVGKNJVYYFTFOB-UHFFFAOYSA-N 0.000 description 1
- OALQOHPDGYLZQW-UHFFFAOYSA-N 5-[3-(4-cyanophenoxy)azetidine-1-carbonyl]-n-[1-[(3,5-difluorophenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound FC1=CC(F)=CC(CN2CCC(CC2)NC(=O)C=2N=CC(=CC=2)C(=O)N2CC(C2)OC=2C=CC(=CC=2)C#N)=C1 OALQOHPDGYLZQW-UHFFFAOYSA-N 0.000 description 1
- WKWOWUPNJQOYOV-UHFFFAOYSA-N 5-[3-(4-cyanophenoxy)azetidine-1-carbonyl]-n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound C=1C=C(C(=O)N2CC(C2)OC=2C=CC(=CC=2)C#N)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 WKWOWUPNJQOYOV-UHFFFAOYSA-N 0.000 description 1
- JGBMPZMXPFSPDG-UHFFFAOYSA-N 5-[3-(4-cyanophenoxy)azetidine-1-carbonyl]-n-[6-(4-fluorophenoxy)pyridin-3-yl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1OC(N=C1)=CC=C1NC(=O)C1=CC=C(C(=O)N2CC(C2)OC=2C=CC(=CC=2)C#N)C=N1 JGBMPZMXPFSPDG-UHFFFAOYSA-N 0.000 description 1
- PYKNAWSLPPFUNW-UHFFFAOYSA-N 5-[3-(4-cyanophenoxy)piperidin-1-yl]-n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound C=1C=C(N2CC(CCC2)OC=2C=CC(=CC=2)C#N)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 PYKNAWSLPPFUNW-UHFFFAOYSA-N 0.000 description 1
- WJFHULPMCHGBBX-UHFFFAOYSA-N 5-[3-(4-cyanophenoxy)piperidine-1-carbonyl]-n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound C=1C=C(C(=O)N2CC(CCC2)OC=2C=CC(=CC=2)C#N)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 WJFHULPMCHGBBX-UHFFFAOYSA-N 0.000 description 1
- BYINZUBHGSJUSR-UHFFFAOYSA-N 5-[3-(4-cyanophenyl)-6,8-dihydro-5h-[1,2,4]triazolo[4,3-a]pyrazine-7-carbonyl]-n-[1-[(3,5-difluorophenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound FC1=CC(F)=CC(CN2CCC(CC2)NC(=O)C=2N=CC(=CC=2)C(=O)N2CC=3N(C(=NN=3)C=3C=CC(=CC=3)C#N)CC2)=C1 BYINZUBHGSJUSR-UHFFFAOYSA-N 0.000 description 1
- NFXJMTPKKPWDFD-UHFFFAOYSA-N 5-[4-(2,4-difluorobenzoyl)piperidine-1-carbonyl]-n-[6-(4-fluorophenoxy)pyridin-3-yl]pyrazine-2-carboxamide Chemical compound C1=CC(F)=CC=C1OC(N=C1)=CC=C1NC(=O)C1=CN=C(C(=O)N2CCC(CC2)C(=O)C=2C(=CC(F)=CC=2)F)C=N1 NFXJMTPKKPWDFD-UHFFFAOYSA-N 0.000 description 1
- DLBGZVFJKSQFKW-UHFFFAOYSA-N 5-[4-(3,4-difluorobenzoyl)piperidine-1-carbonyl]-n-[1-[(3,5-difluorophenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound FC1=CC(F)=CC(CN2CCC(CC2)NC(=O)C=2N=CC(=CC=2)C(=O)N2CCC(CC2)C(=O)C=2C=C(F)C(F)=CC=2)=C1 DLBGZVFJKSQFKW-UHFFFAOYSA-N 0.000 description 1
- DTDPXJTYCFTEEW-UHFFFAOYSA-N 5-[4-(3,4-difluorophenoxy)piperidine-1-carbonyl]-n-[1-[(3,5-difluorophenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound FC1=CC(F)=CC(CN2CCC(CC2)NC(=O)C=2N=CC(=CC=2)C(=O)N2CCC(CC2)OC=2C=C(F)C(F)=CC=2)=C1 DTDPXJTYCFTEEW-UHFFFAOYSA-N 0.000 description 1
- FGBIWVHUOKXSKR-UHFFFAOYSA-N 5-[4-(3-cyanophenoxy)piperidine-1-carbonyl]-n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound C=1C=C(C(=O)N2CCC(CC2)OC=2C=C(C=CC=2)C#N)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 FGBIWVHUOKXSKR-UHFFFAOYSA-N 0.000 description 1
- CZJQSTWTDOMTMC-UHFFFAOYSA-N 5-[4-(4-acetamidophenoxy)piperidine-1-carbonyl]-n-[6-(4-fluorophenoxy)pyridin-3-yl]pyridine-2-carboxamide Chemical compound C1=CC(NC(=O)C)=CC=C1OC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=NC(OC=3C=CC(F)=CC=3)=CC=2)CC1 CZJQSTWTDOMTMC-UHFFFAOYSA-N 0.000 description 1
- CGANLALLTGBPTO-UHFFFAOYSA-N 5-[4-(4-acetylphenoxy)piperidine-1-carbonyl]-n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound C1=CC(C(=O)C)=CC=C1OC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 CGANLALLTGBPTO-UHFFFAOYSA-N 0.000 description 1
- UGQQVZAGWFGYST-UHFFFAOYSA-N 5-[4-(4-acetylphenoxy)piperidine-1-carbonyl]-n-[6-(4-fluorophenoxy)pyridin-3-yl]pyridine-2-carboxamide Chemical compound C1=CC(C(=O)C)=CC=C1OC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=NC(OC=3C=CC(F)=CC=3)=CC=2)CC1 UGQQVZAGWFGYST-UHFFFAOYSA-N 0.000 description 1
- JVERBNBWKSQTRY-UHFFFAOYSA-N 5-[4-(4-chlorobenzoyl)piperidin-1-yl]-n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound C1=CC(Cl)=CC=C1C(=O)C1CCN(C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 JVERBNBWKSQTRY-UHFFFAOYSA-N 0.000 description 1
- VHMVZBCHWOEJTQ-UHFFFAOYSA-N 5-[4-(4-cyano-2-methoxyphenoxy)piperidin-1-yl]-n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound COC1=CC(C#N)=CC=C1OC1CCN(C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 VHMVZBCHWOEJTQ-UHFFFAOYSA-N 0.000 description 1
- KKQGVOSIFWFJDK-UHFFFAOYSA-N 5-[4-(4-cyano-2-methoxyphenoxy)piperidine-1-carbonyl]-n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound COC1=CC(C#N)=CC=C1OC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 KKQGVOSIFWFJDK-UHFFFAOYSA-N 0.000 description 1
- KESKUMQAYVXYTP-UHFFFAOYSA-N 5-[4-(4-cyanobenzoyl)piperidine-1-carbonyl]-N-[4-(4-fluorophenoxy)cyclohexyl]pyridine-2-carboxamide Chemical compound Fc1ccc(OC2CCC(CC2)NC(=O)c2ccc(cn2)C(=O)N2CCC(CC2)C(=O)c2ccc(cc2)C#N)cc1 KESKUMQAYVXYTP-UHFFFAOYSA-N 0.000 description 1
- RMRAPVQTYURKPZ-UHFFFAOYSA-N 5-[4-(4-cyanophenoxy)piperidin-1-yl]-n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound C=1C=C(N2CCC(CC2)OC=2C=CC(=CC=2)C#N)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 RMRAPVQTYURKPZ-UHFFFAOYSA-N 0.000 description 1
- IJCLQUTZPNXGSE-UHFFFAOYSA-N 5-[4-(4-cyanophenoxy)piperidine-1-carbonyl]-N-[4-[4-(trifluoromethyl)phenoxy]cyclohexyl]pyridine-2-carboxamide Chemical compound C1=CC(C(F)(F)F)=CC=C1OC1CCC(NC(=O)C=2N=CC(=CC=2)C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)C#N)CC1 IJCLQUTZPNXGSE-UHFFFAOYSA-N 0.000 description 1
- SGEPABNOVNCCBC-UHFFFAOYSA-N 5-[4-(4-cyanophenoxy)piperidine-1-carbonyl]-n-[1-[(3,5-difluorophenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound FC1=CC(F)=CC(CN2CCC(CC2)NC(=O)C=2N=CC(=CC=2)C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)C#N)=C1 SGEPABNOVNCCBC-UHFFFAOYSA-N 0.000 description 1
- BPMMMRKHRUQAAY-UHFFFAOYSA-N 5-[4-(4-cyanophenoxy)piperidine-1-carbonyl]-n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound C=1C=C(C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)C#N)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 BPMMMRKHRUQAAY-UHFFFAOYSA-N 0.000 description 1
- ZSPDVYPDGBHLED-UHFFFAOYSA-N 5-[4-(4-cyanophenoxy)piperidine-1-carbonyl]-n-[2-(4-fluorophenoxy)ethyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1OCCNC(=O)C1=CC=C(C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)C#N)C=N1 ZSPDVYPDGBHLED-UHFFFAOYSA-N 0.000 description 1
- XZNBTHWUHWCAHY-UHFFFAOYSA-N 5-[4-(4-cyanophenoxy)piperidine-1-carbonyl]-n-[4-(4-fluorophenoxy)cyclohexyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1OC1CCC(NC(=O)C=2N=CC(=CC=2)C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)C#N)CC1 XZNBTHWUHWCAHY-UHFFFAOYSA-N 0.000 description 1
- YUSQDVWUKSSAEC-UHFFFAOYSA-N 5-[4-(4-fluorophenoxy)piperidine-1-carbonyl]-n-[1-[(4-fluorophenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCC(NC(=O)C=2N=CC(=CC=2)C(=O)N2CCC(CC2)OC=2C=CC(F)=CC=2)CC1 YUSQDVWUKSSAEC-UHFFFAOYSA-N 0.000 description 1
- GQLHMTROMKDTKQ-UHFFFAOYSA-N 5-[4-(4-fluorophenoxy)piperidine-1-carbonyl]-n-[1-[(4-methoxyphenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1CN1CCC(NC(=O)C=2N=CC(=CC=2)C(=O)N2CCC(CC2)OC=2C=CC(F)=CC=2)CC1 GQLHMTROMKDTKQ-UHFFFAOYSA-N 0.000 description 1
- CIXKEBBNLUBQNZ-UHFFFAOYSA-N 5-[4-(4-fluorophenoxy)piperidine-1-carbonyl]-n-[6-(4-fluorophenoxy)pyridin-3-yl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1OC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=NC(OC=3C=CC(F)=CC=3)=CC=2)CC1 CIXKEBBNLUBQNZ-UHFFFAOYSA-N 0.000 description 1
- QJSNZYYRFPKWGV-UHFFFAOYSA-N 5-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]-N-[4-(4-methoxyphenoxy)phenyl]pyridine-2-carboxamide Chemical compound COc1ccc(Oc2ccc(NC(=O)c3ccc(cn3)C(=O)N3CCC(CC3)C(=O)c3ccc(OC)cc3)cc2)cc1 QJSNZYYRFPKWGV-UHFFFAOYSA-N 0.000 description 1
- SWQOOGAKPQTEBM-UHFFFAOYSA-N 5-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]-N-[4-[4-(trifluoromethyl)phenoxy]cyclohexyl]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCC(CC2)OC=2C=CC(=CC=2)C(F)(F)F)CC1 SWQOOGAKPQTEBM-UHFFFAOYSA-N 0.000 description 1
- SHXRZVBBZQBCEM-UHFFFAOYSA-N 5-[4-(4-methoxyphenoxy)piperidine-1-carbonyl]-N-[4-[4-(trifluoromethyl)phenoxy]cyclohexyl]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1OC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCC(CC2)OC=2C=CC(=CC=2)C(F)(F)F)CC1 SHXRZVBBZQBCEM-UHFFFAOYSA-N 0.000 description 1
- NTWQKRFJFGQARC-UHFFFAOYSA-N 5-[4-(4-methylsulfonylphenoxy)piperidine-1-carbonyl]-n-[1-[(4-pyrrolidin-1-ylphenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound C1=CC(S(=O)(=O)C)=CC=C1OC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)N3CCCC3)CC2)CC1 NTWQKRFJFGQARC-UHFFFAOYSA-N 0.000 description 1
- GAPLEWRIBFUXRK-UHFFFAOYSA-N 5-[4-(4-methylsulfonylphenoxy)piperidine-1-carbonyl]-n-[1-[[3-(trifluoromethoxy)phenyl]methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound C1=CC(S(=O)(=O)C)=CC=C1OC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=C(OC(F)(F)F)C=CC=3)CC2)CC1 GAPLEWRIBFUXRK-UHFFFAOYSA-N 0.000 description 1
- UFEIEYBIRIUWRQ-UHFFFAOYSA-N 5-[4-(benzenesulfonyl)piperazine-1-carbonyl]-n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound C=1C=C(C(=O)N2CCN(CC2)S(=O)(=O)C=2C=CC=CC=2)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 UFEIEYBIRIUWRQ-UHFFFAOYSA-N 0.000 description 1
- ZSDOZPPRAYGYEU-UHFFFAOYSA-N 5-[4-[(4-cyanophenyl)methyl]piperazine-1-carbonyl]-n-[1-[(4-methoxyphenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1CN1CCC(NC(=O)C=2N=CC(=CC=2)C(=O)N2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 ZSDOZPPRAYGYEU-UHFFFAOYSA-N 0.000 description 1
- MRMDURIHTGUZQI-UHFFFAOYSA-N 5-[4-[(4-cyanophenyl)methyl]piperidine-1-carbonyl]-n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound C=1C=C(C(=O)N2CCC(CC=3C=CC(=CC=3)C#N)CC2)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 MRMDURIHTGUZQI-UHFFFAOYSA-N 0.000 description 1
- HQTGOKGRHCNFPD-UHFFFAOYSA-N 5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]-n-(1-phenylpiperidin-4-yl)pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC2)C=2C=CC=CC=2)CC1 HQTGOKGRHCNFPD-UHFFFAOYSA-N 0.000 description 1
- DKZIWVLUHXKRHI-UHFFFAOYSA-N 5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]-n-(2-phenylphenyl)pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C(=CC=CC=2)C=2C=CC=CC=2)CC1 DKZIWVLUHXKRHI-UHFFFAOYSA-N 0.000 description 1
- CQQMMXMEYNOOTM-UHFFFAOYSA-N 5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]-n-(3-phenoxyphenyl)pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=C(OC=3C=CC=CC=3)C=CC=2)CC1 CQQMMXMEYNOOTM-UHFFFAOYSA-N 0.000 description 1
- DEAYGZRRXFNGTA-UHFFFAOYSA-N 5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]-n-(3-phenylphenyl)pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=C(C=CC=2)C=2C=CC=CC=2)CC1 DEAYGZRRXFNGTA-UHFFFAOYSA-N 0.000 description 1
- VHXPMMSGAZXAOF-UHFFFAOYSA-N 5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]-n-(4-morpholin-4-ylphenyl)pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=CC(=CC=2)N2CCOCC2)CC1 VHXPMMSGAZXAOF-UHFFFAOYSA-N 0.000 description 1
- KFWUZHLIUCMOPR-UHFFFAOYSA-N 5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]-n-(4-phenoxyphenyl)pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=CC(OC=3C=CC=CC=3)=CC=2)CC1 KFWUZHLIUCMOPR-UHFFFAOYSA-N 0.000 description 1
- IKKVPXFGSRKNJV-UHFFFAOYSA-N 5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]-n-(4-phenylmethoxyphenyl)pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=CC(OCC=3C=CC=CC=3)=CC=2)CC1 IKKVPXFGSRKNJV-UHFFFAOYSA-N 0.000 description 1
- PRJISZJJPGFGHG-UHFFFAOYSA-N 5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]-n-(4-phenylphenyl)pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=CC(=CC=2)C=2C=CC=CC=2)CC1 PRJISZJJPGFGHG-UHFFFAOYSA-N 0.000 description 1
- BJRZKIVEUFLPAU-UHFFFAOYSA-N 5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]-n-(4-thiophen-3-ylphenyl)pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=CC(=CC=2)C2=CSC=C2)CC1 BJRZKIVEUFLPAU-UHFFFAOYSA-N 0.000 description 1
- OTTMHRBJZANTRA-UHFFFAOYSA-N 5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]-n-[1-(1-phenylethyl)piperidin-4-yl]pyridine-2-carboxamide Chemical compound C=1C=CC=CC=1C(C)N(CC1)CCC1NC(=O)C(N=C1)=CC=C1C(=O)N(CC1)CCN1CC1=CC=C(F)C=C1 OTTMHRBJZANTRA-UHFFFAOYSA-N 0.000 description 1
- JBOAVLPHPAENSA-UHFFFAOYSA-N 5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]-n-[1-[(4-methoxyphenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1CN1CCC(NC(=O)C=2N=CC(=CC=2)C(=O)N2CCN(CC=3C=CC(F)=CC=3)CC2)CC1 JBOAVLPHPAENSA-UHFFFAOYSA-N 0.000 description 1
- ANLDAUPWGMIDKB-UHFFFAOYSA-N 5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]-n-[4-(1h-pyrrol-3-yl)phenyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=CC(=CC=2)C2=CNC=C2)CC1 ANLDAUPWGMIDKB-UHFFFAOYSA-N 0.000 description 1
- WDGGQCRMJXHVAD-UHFFFAOYSA-N 5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]-n-[4-(3-methoxyphenoxy)phenyl]pyridine-2-carboxamide Chemical compound COC1=CC=CC(OC=2C=CC(NC(=O)C=3N=CC(=CC=3)C(=O)N3CCN(CC=4C=CC(F)=CC=4)CC3)=CC=2)=C1 WDGGQCRMJXHVAD-UHFFFAOYSA-N 0.000 description 1
- CBGKMLBDMVQWBH-UHFFFAOYSA-N 5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]-n-[4-(3-methylphenoxy)phenyl]pyridine-2-carboxamide Chemical compound CC1=CC=CC(OC=2C=CC(NC(=O)C=3N=CC(=CC=3)C(=O)N3CCN(CC=4C=CC(F)=CC=4)CC3)=CC=2)=C1 CBGKMLBDMVQWBH-UHFFFAOYSA-N 0.000 description 1
- RDGQWELXIWGGAA-UHFFFAOYSA-N 5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]-n-[4-(4-methoxyphenoxy)phenyl]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1OC(C=C1)=CC=C1NC(=O)C1=CC=C(C(=O)N2CCN(CC=3C=CC(F)=CC=3)CC2)C=N1 RDGQWELXIWGGAA-UHFFFAOYSA-N 0.000 description 1
- DVMILXSBZSNOPF-UHFFFAOYSA-N 5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]-n-[4-(4-methoxyphenyl)phenyl]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1C(C=C1)=CC=C1NC(=O)C1=CC=C(C(=O)N2CCN(CC=3C=CC(F)=CC=3)CC2)C=N1 DVMILXSBZSNOPF-UHFFFAOYSA-N 0.000 description 1
- RMWNMWQMKJQMNP-UHFFFAOYSA-N 5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]-n-[4-(4-methylphenoxy)phenyl]pyridine-2-carboxamide Chemical compound C1=CC(C)=CC=C1OC(C=C1)=CC=C1NC(=O)C1=CC=C(C(=O)N2CCN(CC=3C=CC(F)=CC=3)CC2)C=N1 RMWNMWQMKJQMNP-UHFFFAOYSA-N 0.000 description 1
- GAYRGESOQUQOTJ-UHFFFAOYSA-N 5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]-n-[4-(4-nitrophenyl)phenyl]pyridine-2-carboxamide Chemical compound C1=CC([N+](=O)[O-])=CC=C1C(C=C1)=CC=C1NC(=O)C1=CC=C(C(=O)N2CCN(CC=3C=CC(F)=CC=3)CC2)C=N1 GAYRGESOQUQOTJ-UHFFFAOYSA-N 0.000 description 1
- RBSXAXHVCUKMIZ-UHFFFAOYSA-N 5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]-n-[4-[4-(trifluoromethyl)phenyl]phenyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=CC(=CC=2)C=2C=CC(=CC=2)C(F)(F)F)CC1 RBSXAXHVCUKMIZ-UHFFFAOYSA-N 0.000 description 1
- AUDCQJXZPQEOHW-UHFFFAOYSA-N 5-[[1-(4-chlorophenyl)piperidin-4-yl]amino]-n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound C1=CC(Cl)=CC=C1N1CCC(NC=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 AUDCQJXZPQEOHW-UHFFFAOYSA-N 0.000 description 1
- OOEKCGKFHYHSPV-UHFFFAOYSA-N 6-(4-benzylpiperazine-1-carbonyl)-n-(1-benzylpiperidin-4-yl)pyridine-3-carboxamide Chemical compound C=1C=C(C(=O)N2CCN(CC=3C=CC=CC=3)CC2)N=CC=1C(=O)NC(CC1)CCN1CC1=CC=CC=C1 OOEKCGKFHYHSPV-UHFFFAOYSA-N 0.000 description 1
- FXHBRSQJDSUPGH-UHFFFAOYSA-N 6-[4-(2,4-difluorobenzoyl)piperidine-1-carbonyl]-n-[1-[(4-methylsulfonylphenyl)methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(S(=O)(=O)C)=CC=C1CN1CCC(NC(=O)C=2C=NC(=CC=2)C(=O)N2CCC(CC2)C(=O)C=2C(=CC(F)=CC=2)F)CC1 FXHBRSQJDSUPGH-UHFFFAOYSA-N 0.000 description 1
- PLFKPSQUHVQKGD-UHFFFAOYSA-N 6-[4-(2,4-difluorobenzoyl)piperidine-1-carbonyl]-n-[1-[[4-(methanesulfonamido)phenyl]methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(NS(=O)(=O)C)=CC=C1CN1CCC(NC(=O)C=2C=NC(=CC=2)C(=O)N2CCC(CC2)C(=O)C=2C(=CC(F)=CC=2)F)CC1 PLFKPSQUHVQKGD-UHFFFAOYSA-N 0.000 description 1
- MMDHXUCOBFMXDW-UHFFFAOYSA-N 6-[4-(2,4-difluorobenzoyl)piperidine-1-carbonyl]-n-[6-(4-fluorophenoxy)pyridin-3-yl]pyridine-3-carboxamide Chemical compound C1=CC(F)=CC=C1OC(N=C1)=CC=C1NC(=O)C1=CC=C(C(=O)N2CCC(CC2)C(=O)C=2C(=CC(F)=CC=2)F)N=C1 MMDHXUCOBFMXDW-UHFFFAOYSA-N 0.000 description 1
- YJVUDJAYUHJDRZ-UHFFFAOYSA-N 6-[4-(2,4-difluorobenzoyl)piperidine-1-carbonyl]-n-[6-(4-methylsulfonylphenoxy)pyridin-3-yl]pyridine-3-carboxamide Chemical compound C1=CC(S(=O)(=O)C)=CC=C1OC(N=C1)=CC=C1NC(=O)C1=CC=C(C(=O)N2CCC(CC2)C(=O)C=2C(=CC(F)=CC=2)F)N=C1 YJVUDJAYUHJDRZ-UHFFFAOYSA-N 0.000 description 1
- CSMZDTSEHGVTML-UHFFFAOYSA-N 6-[4-(2,4-difluorobenzoyl)piperidine-1-carbonyl]-n-[6-[4-(dimethylcarbamoyl)phenoxy]pyridin-3-yl]pyridine-3-carboxamide Chemical compound C1=CC(C(=O)N(C)C)=CC=C1OC(N=C1)=CC=C1NC(=O)C1=CC=C(C(=O)N2CCC(CC2)C(=O)C=2C(=CC(F)=CC=2)F)N=C1 CSMZDTSEHGVTML-UHFFFAOYSA-N 0.000 description 1
- GUJSBGWSDRFUAC-UHFFFAOYSA-N 6-[4-(2,4-difluorophenoxy)piperidine-1-carbonyl]-n-[6-(4-fluorophenoxy)pyridin-3-yl]pyridine-3-carboxamide Chemical compound C1=CC(F)=CC=C1OC(N=C1)=CC=C1NC(=O)C1=CC=C(C(=O)N2CCC(CC2)OC=2C(=CC(F)=CC=2)F)N=C1 GUJSBGWSDRFUAC-UHFFFAOYSA-N 0.000 description 1
- YBCMWZLNHLQBTF-UHFFFAOYSA-N 6-[4-(3-acetamidophenoxy)piperidine-1-carbonyl]-n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound CC(=O)NC1=CC=CC(OC2CCN(CC2)C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)=C1 YBCMWZLNHLQBTF-UHFFFAOYSA-N 0.000 description 1
- QAQJNUIVHQIXNU-UHFFFAOYSA-N 6-[4-(3-acetamidophenoxy)piperidine-1-carbonyl]-n-[1-[(4-fluorophenyl)methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound CC(=O)NC1=CC=CC(OC2CCN(CC2)C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=CC(F)=CC=3)CC2)=C1 QAQJNUIVHQIXNU-UHFFFAOYSA-N 0.000 description 1
- UFIJHORMJXQIKW-UHFFFAOYSA-N 6-[4-(3-acetamidophenoxy)piperidine-1-carbonyl]-n-[1-[(4-methoxyphenyl)methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1CN1CCC(NC(=O)C=2C=NC(=CC=2)C(=O)N2CCC(CC2)OC=2C=C(NC(C)=O)C=CC=2)CC1 UFIJHORMJXQIKW-UHFFFAOYSA-N 0.000 description 1
- HJAZSWLXYPIMTM-UHFFFAOYSA-N 6-[4-(3-acetamidophenoxy)piperidine-1-carbonyl]-n-[1-[[3-(trifluoromethoxy)phenyl]methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound CC(=O)NC1=CC=CC(OC2CCN(CC2)C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=C(OC(F)(F)F)C=CC=3)CC2)=C1 HJAZSWLXYPIMTM-UHFFFAOYSA-N 0.000 description 1
- HFTJORLORZXKEZ-UHFFFAOYSA-N 6-[4-(3-acetamidophenoxy)piperidine-1-carbonyl]-n-[6-(4-fluorophenoxy)pyridin-3-yl]pyridine-3-carboxamide Chemical compound CC(=O)NC1=CC=CC(OC2CCN(CC2)C(=O)C=2N=CC(=CC=2)C(=O)NC=2C=NC(OC=3C=CC(F)=CC=3)=CC=2)=C1 HFTJORLORZXKEZ-UHFFFAOYSA-N 0.000 description 1
- GNMBIYXIFWVHBU-UHFFFAOYSA-N 6-[4-(4-acetamidophenoxy)piperidine-1-carbonyl]-n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(NC(=O)C)=CC=C1OC1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 GNMBIYXIFWVHBU-UHFFFAOYSA-N 0.000 description 1
- YQMZZWAQXKEZOB-UHFFFAOYSA-N 6-[4-(4-acetamidophenoxy)piperidine-1-carbonyl]-n-[1-[(4-fluorophenyl)methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(NC(=O)C)=CC=C1OC1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=CC(F)=CC=3)CC2)CC1 YQMZZWAQXKEZOB-UHFFFAOYSA-N 0.000 description 1
- XYVPQYHJOMNWFW-UHFFFAOYSA-N 6-[4-(4-acetamidophenoxy)piperidine-1-carbonyl]-n-[1-[(4-methoxyphenyl)methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1CN1CCC(NC(=O)C=2C=NC(=CC=2)C(=O)N2CCC(CC2)OC=2C=CC(NC(C)=O)=CC=2)CC1 XYVPQYHJOMNWFW-UHFFFAOYSA-N 0.000 description 1
- NXUARYUTSSUSSG-UHFFFAOYSA-N 6-[4-(4-acetamidophenoxy)piperidine-1-carbonyl]-n-[1-[[3-(trifluoromethoxy)phenyl]methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(NC(=O)C)=CC=C1OC1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=C(OC(F)(F)F)C=CC=3)CC2)CC1 NXUARYUTSSUSSG-UHFFFAOYSA-N 0.000 description 1
- ACJLYGUYLHGBRM-UHFFFAOYSA-N 6-[4-(4-acetylphenoxy)piperidine-1-carbonyl]-n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridazine-3-carboxamide Chemical compound C1=CC(C(=O)C)=CC=C1OC1CCN(C(=O)C=2N=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 ACJLYGUYLHGBRM-UHFFFAOYSA-N 0.000 description 1
- VPANDGDZYUHJNA-UHFFFAOYSA-N 6-[4-(4-acetylphenoxy)piperidine-1-carbonyl]-n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(C(=O)C)=CC=C1OC1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 VPANDGDZYUHJNA-UHFFFAOYSA-N 0.000 description 1
- KSGRCIGWEWONAI-UHFFFAOYSA-N 6-[4-(4-acetylphenoxy)piperidine-1-carbonyl]-n-[1-[(4-fluorophenyl)methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(C(=O)C)=CC=C1OC1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=CC(F)=CC=3)CC2)CC1 KSGRCIGWEWONAI-UHFFFAOYSA-N 0.000 description 1
- RKZZIRZVMZFRAJ-UHFFFAOYSA-N 6-[4-(4-acetylphenoxy)piperidine-1-carbonyl]-n-[4-(4-cyanophenoxy)cyclohexyl]pyridine-3-carboxamide Chemical compound C1=CC(C(=O)C)=CC=C1OC1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCC(CC2)OC=2C=CC(=CC=2)C#N)CC1 RKZZIRZVMZFRAJ-UHFFFAOYSA-N 0.000 description 1
- PCKCBYIEMJBCQJ-UHFFFAOYSA-N 6-[4-(4-acetylphenoxy)piperidine-1-carbonyl]-n-[6-(4-fluorophenoxy)pyridin-3-yl]pyridine-3-carboxamide Chemical compound C1=CC(C(=O)C)=CC=C1OC1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC=2C=NC(OC=3C=CC(F)=CC=3)=CC=2)CC1 PCKCBYIEMJBCQJ-UHFFFAOYSA-N 0.000 description 1
- NSZYFVPQFQAZIY-UHFFFAOYSA-N 6-[4-(4-cyanophenoxy)piperidin-1-yl]-n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridazine-3-carboxamide Chemical compound C=1C=C(N2CCC(CC2)OC=2C=CC(=CC=2)C#N)N=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 NSZYFVPQFQAZIY-UHFFFAOYSA-N 0.000 description 1
- MZHVANYWYUEJSQ-UHFFFAOYSA-N 6-[4-(4-cyanophenoxy)piperidine-1-carbonyl]-n-[1-(1,3-oxazol-4-ylmethyl)piperidin-4-yl]pyridine-3-carboxamide Chemical compound C=1C=C(C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)C#N)N=CC=1C(=O)NC(CC1)CCN1CC1=COC=N1 MZHVANYWYUEJSQ-UHFFFAOYSA-N 0.000 description 1
- AMGOYODSYQCBIL-UHFFFAOYSA-N 6-[4-(4-cyanophenoxy)piperidine-1-carbonyl]-n-[1-(4-cyanophenyl)piperidin-4-yl]pyridine-3-carboxamide Chemical compound C=1C=C(C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)C#N)N=CC=1C(=O)NC(CC1)CCN1C1=CC=C(C#N)C=C1 AMGOYODSYQCBIL-UHFFFAOYSA-N 0.000 description 1
- XDHLQPZDWFLLBX-UHFFFAOYSA-N 6-[4-(4-cyanophenoxy)piperidine-1-carbonyl]-n-[1-(4-methoxyphenyl)piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1N1CCC(NC(=O)C=2C=NC(=CC=2)C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)C#N)CC1 XDHLQPZDWFLLBX-UHFFFAOYSA-N 0.000 description 1
- RWRQJVGLXNKXAI-UHFFFAOYSA-N 6-[4-(4-cyanophenoxy)piperidine-1-carbonyl]-n-[1-(4-methylsulfonylphenyl)piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1CCC(NC(=O)C=2C=NC(=CC=2)C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)C#N)CC1 RWRQJVGLXNKXAI-UHFFFAOYSA-N 0.000 description 1
- DVERKLBRNMUJHI-UHFFFAOYSA-N 6-[4-(4-cyanophenoxy)piperidine-1-carbonyl]-n-[1-[(3,5-difluorophenyl)methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound FC1=CC(F)=CC(CN2CCC(CC2)NC(=O)C=2C=NC(=CC=2)C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)C#N)=C1 DVERKLBRNMUJHI-UHFFFAOYSA-N 0.000 description 1
- BZJYUHBEBJBKFU-UHFFFAOYSA-N 6-[4-(4-cyanophenoxy)piperidine-1-carbonyl]-n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridazine-3-carboxamide Chemical compound C=1C=C(C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)C#N)N=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 BZJYUHBEBJBKFU-UHFFFAOYSA-N 0.000 description 1
- ZXOKHOODFVNZIC-UHFFFAOYSA-N 6-[4-(4-cyanophenoxy)piperidine-1-carbonyl]-n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C=1C=C(C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)C#N)N=CC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 ZXOKHOODFVNZIC-UHFFFAOYSA-N 0.000 description 1
- CJNVQFBBNTVLGQ-UHFFFAOYSA-N 6-[4-(4-cyanophenoxy)piperidine-1-carbonyl]-n-[1-[(4-fluorophenyl)methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCC(NC(=O)C=2C=NC(=CC=2)C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)C#N)CC1 CJNVQFBBNTVLGQ-UHFFFAOYSA-N 0.000 description 1
- KBPBPTZMSUNTBK-UHFFFAOYSA-N 6-[4-(4-cyanophenoxy)piperidine-1-carbonyl]-n-[1-[(4-methoxyphenyl)methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1CN1CCC(NC(=O)C=2C=NC(=CC=2)C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)C#N)CC1 KBPBPTZMSUNTBK-UHFFFAOYSA-N 0.000 description 1
- RQSXOONFDVZBCK-UHFFFAOYSA-N 6-[4-(4-cyanophenoxy)piperidine-1-carbonyl]-n-[1-[(4-methylsulfonylphenyl)methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(S(=O)(=O)C)=CC=C1CN1CCC(NC(=O)C=2C=NC(=CC=2)C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)C#N)CC1 RQSXOONFDVZBCK-UHFFFAOYSA-N 0.000 description 1
- FKPBNJOZUYPWPE-UHFFFAOYSA-N 6-[4-(4-cyanophenoxy)piperidine-1-carbonyl]-n-[1-[(4-morpholin-4-ylphenyl)methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C=1C=C(C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)C#N)N=CC=1C(=O)NC(CC1)CCN1CC(C=C1)=CC=C1N1CCOCC1 FKPBNJOZUYPWPE-UHFFFAOYSA-N 0.000 description 1
- KHXARCSTRQBUHC-UHFFFAOYSA-N 6-[4-(4-cyanophenoxy)piperidine-1-carbonyl]-n-[1-[[4-(methanesulfonamido)phenyl]methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(NS(=O)(=O)C)=CC=C1CN1CCC(NC(=O)C=2C=NC(=CC=2)C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)C#N)CC1 KHXARCSTRQBUHC-UHFFFAOYSA-N 0.000 description 1
- DSZCBNUFKPZERX-UHFFFAOYSA-N 6-[4-(4-cyanophenoxy)piperidine-1-carbonyl]-n-[1-[[4-(trifluoromethoxy)phenyl]methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(OC(F)(F)F)=CC=C1CN1CCC(NC(=O)C=2C=NC(=CC=2)C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)C#N)CC1 DSZCBNUFKPZERX-UHFFFAOYSA-N 0.000 description 1
- ODCYZWPLGOHHLR-UHFFFAOYSA-N 6-[4-(4-cyanophenoxy)piperidine-1-carbonyl]-n-[4-(4-fluorophenoxy)cyclohexyl]pyridine-3-carboxamide Chemical compound C1=CC(F)=CC=C1OC1CCC(NC(=O)C=2C=NC(=CC=2)C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)C#N)CC1 ODCYZWPLGOHHLR-UHFFFAOYSA-N 0.000 description 1
- XSUNUTFPDUBUTM-UHFFFAOYSA-N 6-[4-(4-cyanophenoxy)piperidine-1-carbonyl]-n-[6-(4-fluorophenoxy)pyridin-3-yl]pyridine-3-carboxamide Chemical compound C1=CC(F)=CC=C1OC(N=C1)=CC=C1NC(=O)C1=CC=C(C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)C#N)N=C1 XSUNUTFPDUBUTM-UHFFFAOYSA-N 0.000 description 1
- WTXNEQJNAQMKMM-UHFFFAOYSA-N 6-[4-(4-cyclopropylsulfonylphenoxy)piperidine-1-carbonyl]-n-[1-[(4-pyrrolidin-1-ylphenyl)methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C=1C=C(C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)S(=O)(=O)C2CC2)N=CC=1C(=O)NC(CC1)CCN1CC(C=C1)=CC=C1N1CCCC1 WTXNEQJNAQMKMM-UHFFFAOYSA-N 0.000 description 1
- LOCVLBUUUHGTAV-UHFFFAOYSA-N 6-[4-(4-cyclopropylsulfonylphenoxy)piperidine-1-carbonyl]-n-[1-[[4-(trifluoromethoxy)phenyl]methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(OC(F)(F)F)=CC=C1CN1CCC(NC(=O)C=2C=NC(=CC=2)C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)S(=O)(=O)C2CC2)CC1 LOCVLBUUUHGTAV-UHFFFAOYSA-N 0.000 description 1
- ZZWJDICOSBHOKT-UHFFFAOYSA-N 6-[4-(4-cyclopropylsulfonylphenoxy)piperidine-1-carbonyl]-n-[6-(4-fluorophenoxy)pyridin-3-yl]pyridine-3-carboxamide Chemical compound C1=CC(F)=CC=C1OC(N=C1)=CC=C1NC(=O)C1=CC=C(C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)S(=O)(=O)C2CC2)N=C1 ZZWJDICOSBHOKT-UHFFFAOYSA-N 0.000 description 1
- KCEAIMNCDQJEOH-UHFFFAOYSA-N 6-[4-(4-fluorophenyl)sulfonylpiperidine-1-carbonyl]-n-[1-[[4-(trifluoromethoxy)phenyl]methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(F)=CC=C1S(=O)(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=CC(OC(F)(F)F)=CC=3)CC2)CC1 KCEAIMNCDQJEOH-UHFFFAOYSA-N 0.000 description 1
- HHOJNLQASSTSAG-UHFFFAOYSA-N 6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]-n-[1-[(4-methoxyphenyl)methyl]piperidin-4-yl]-n-methylpyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1CN1CCC(N(C)C(=O)C=2C=NC(=CC=2)C(=O)N2CCC(CC2)C(=O)C=2C=CC(OC)=CC=2)CC1 HHOJNLQASSTSAG-UHFFFAOYSA-N 0.000 description 1
- DRTNBWSDTRSDFI-UHFFFAOYSA-N 6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]-n-[1-[[3-(trifluoromethoxy)phenyl]methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=C(OC(F)(F)F)C=CC=3)CC2)CC1 DRTNBWSDTRSDFI-UHFFFAOYSA-N 0.000 description 1
- ZWIGVNWZHBPXNS-UHFFFAOYSA-N 6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]-n-[1-[[4-(trifluoromethoxy)phenyl]methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=CC(OC(F)(F)F)=CC=3)CC2)CC1 ZWIGVNWZHBPXNS-UHFFFAOYSA-N 0.000 description 1
- WWMWPFIHGSDSJL-UHFFFAOYSA-N 6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]-n-[6-(4-methylsulfonylphenoxy)pyridin-3-yl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC=2C=NC(OC=3C=CC(=CC=3)S(C)(=O)=O)=CC=2)CC1 WWMWPFIHGSDSJL-UHFFFAOYSA-N 0.000 description 1
- MEOATWALOAIMIC-UHFFFAOYSA-N 6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]-n-methyl-n-[1-[[4-(trifluoromethoxy)phenyl]methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)N(C)C2CCN(CC=3C=CC(OC(F)(F)F)=CC=3)CC2)CC1 MEOATWALOAIMIC-UHFFFAOYSA-N 0.000 description 1
- NVACMJIIIPZMMM-UHFFFAOYSA-N 6-[4-(4-methoxyphenoxy)piperidine-1-carbonyl]-N-[1-[(4-methylsulfonylphenyl)methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound COc1ccc(OC2CCN(CC2)C(=O)c2ccc(cn2)C(=O)NC2CCN(Cc3ccc(cc3)S(C)(=O)=O)CC2)cc1 NVACMJIIIPZMMM-UHFFFAOYSA-N 0.000 description 1
- CSBDVKDQMZPDIN-UHFFFAOYSA-N 6-[4-(4-methylsulfonylphenoxy)piperidine-1-carbonyl]-n-[1-[(4-pyrrolidin-1-ylphenyl)methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(S(=O)(=O)C)=CC=C1OC1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)N3CCCC3)CC2)CC1 CSBDVKDQMZPDIN-UHFFFAOYSA-N 0.000 description 1
- HLFMHUFIGPKBDK-UHFFFAOYSA-N 6-[4-(4-methylsulfonylphenoxy)piperidine-1-carbonyl]-n-[1-[[3-(trifluoromethoxy)phenyl]methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(S(=O)(=O)C)=CC=C1OC1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=C(OC(F)(F)F)C=CC=3)CC2)CC1 HLFMHUFIGPKBDK-UHFFFAOYSA-N 0.000 description 1
- IRZRWLCHLOQQMF-UHFFFAOYSA-N 6-[4-(4-pyrrolidin-1-ylbenzoyl)piperidine-1-carbonyl]-n-[1-[[3-(trifluoromethoxy)phenyl]methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound FC(F)(F)OC1=CC=CC(CN2CCC(CC2)NC(=O)C=2C=NC(=CC=2)C(=O)N2CCC(CC2)C(=O)C=2C=CC(=CC=2)N2CCCC2)=C1 IRZRWLCHLOQQMF-UHFFFAOYSA-N 0.000 description 1
- CYFFRIPWULCMAW-UHFFFAOYSA-N 6-[4-(4-pyrrolidin-1-ylbenzoyl)piperidine-1-carbonyl]-n-[1-[[4-(trifluoromethoxy)phenyl]methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(OC(F)(F)F)=CC=C1CN1CCC(NC(=O)C=2C=NC(=CC=2)C(=O)N2CCC(CC2)C(=O)C=2C=CC(=CC=2)N2CCCC2)CC1 CYFFRIPWULCMAW-UHFFFAOYSA-N 0.000 description 1
- VGOONDYBJSKCBN-UHFFFAOYSA-N 6-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]-n-[1-(4-fluorophenyl)piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC2)C=2C=CC(F)=CC=2)CC1 VGOONDYBJSKCBN-UHFFFAOYSA-N 0.000 description 1
- FKSSSDMQVIYXCQ-UHFFFAOYSA-N 6-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]-n-[1-(4-methoxyphenyl)piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1N1CCC(NC(=O)C=2C=NC(=CC=2)C(=O)N2CCN(CC=3C=CC(F)=CC=3)CC2)CC1 FKSSSDMQVIYXCQ-UHFFFAOYSA-N 0.000 description 1
- BOMYFXTYBRETRO-UHFFFAOYSA-N 6-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]-n-[1-(4-methylsulfonylphenyl)piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1CCC(NC(=O)C=2C=NC(=CC=2)C(=O)N2CCN(CC=3C=CC(F)=CC=3)CC2)CC1 BOMYFXTYBRETRO-UHFFFAOYSA-N 0.000 description 1
- JKAJRLZIQKBLFQ-UHFFFAOYSA-N 6-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]-n-[1-[(4-fluorophenyl)methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCC(NC(=O)C=2C=NC(=CC=2)C(=O)N2CCN(CC=3C=CC(F)=CC=3)CC2)CC1 JKAJRLZIQKBLFQ-UHFFFAOYSA-N 0.000 description 1
- OUYBMULCCUWUIY-UHFFFAOYSA-N 6-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]-n-[1-[(4-methoxyphenyl)methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1CN1CCC(NC(=O)C=2C=NC(=CC=2)C(=O)N2CCN(CC=3C=CC(F)=CC=3)CC2)CC1 OUYBMULCCUWUIY-UHFFFAOYSA-N 0.000 description 1
- ZEJJGUPFZSMWAX-UHFFFAOYSA-N 6-[4-[3-(cyclopropanecarbonylamino)phenoxy]piperidine-1-carbonyl]-n-[1-[[4-(trifluoromethoxy)phenyl]methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(OC(F)(F)F)=CC=C1CN1CCC(NC(=O)C=2C=NC(=CC=2)C(=O)N2CCC(CC2)OC=2C=C(NC(=O)C3CC3)C=CC=2)CC1 ZEJJGUPFZSMWAX-UHFFFAOYSA-N 0.000 description 1
- BSKIKGJMGXCCRR-UHFFFAOYSA-N 6-[4-[4-(4-methylpiperazin-1-yl)benzoyl]piperidine-1-carbonyl]-n-[1-[[4-(trifluoromethoxy)phenyl]methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1CN(C)CCN1C1=CC=C(C(=O)C2CCN(CC2)C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=CC(OC(F)(F)F)=CC=3)CC2)C=C1 BSKIKGJMGXCCRR-UHFFFAOYSA-N 0.000 description 1
- VUYRMWJLJSPEAR-UHFFFAOYSA-N 6-[4-[4-(cyclopropanecarbonyl)phenoxy]piperidine-1-carbonyl]-n-[1-[[4-(trifluoromethoxy)phenyl]methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(OC(F)(F)F)=CC=C1CN1CCC(NC(=O)C=2C=NC(=CC=2)C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)C(=O)C2CC2)CC1 VUYRMWJLJSPEAR-UHFFFAOYSA-N 0.000 description 1
- YWDIAISASAOPKH-UHFFFAOYSA-N 6-[4-[4-(cyclopropanecarbonyl)phenoxy]piperidine-1-carbonyl]-n-[6-(4-fluorophenoxy)pyridin-3-yl]pyridine-3-carboxamide Chemical compound C1=CC(F)=CC=C1OC(N=C1)=CC=C1NC(=O)C1=CC=C(C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)C(=O)C2CC2)N=C1 YWDIAISASAOPKH-UHFFFAOYSA-N 0.000 description 1
- IRXMWPNSDLENHP-UHFFFAOYSA-N 6-[4-[4-(pentafluoro-$l^{6}-sulfanyl)phenoxy]piperidine-1-carbonyl]-n-[1-[[4-(trifluoromethoxy)phenyl]methyl]piperidin-4-yl]pyridine-3-carboxamide Chemical compound C1=CC(OC(F)(F)F)=CC=C1CN1CCC(NC(=O)C=2C=NC(=CC=2)C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)S(F)(F)(F)(F)F)CC1 IRXMWPNSDLENHP-UHFFFAOYSA-N 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- YSAKXSLSNHUKPX-UHFFFAOYSA-N C(C1=CN=CC=C1)(=O)NC1CCN(CC1)CC1=CC=C(C=C1)N1CCCC1 Chemical compound C(C1=CN=CC=C1)(=O)NC1CCN(CC1)CC1=CC=C(C=C1)N1CCCC1 YSAKXSLSNHUKPX-UHFFFAOYSA-N 0.000 description 1
- KZZKCAHRHQVUET-UHFFFAOYSA-N C1=CC(OC)=CC=C1CN1CCC(NC(=O)C=2N=CC(=CC=2)C(=O)N2CCC(CC2)C(=O)C=2C=CC(C)=CC=2)CC1 Chemical compound C1=CC(OC)=CC=C1CN1CCC(NC(=O)C=2N=CC(=CC=2)C(=O)N2CCC(CC2)C(=O)C=2C=CC(C)=CC=2)CC1 KZZKCAHRHQVUET-UHFFFAOYSA-N 0.000 description 1
- KGDGVGWNVIEHQL-UHFFFAOYSA-N C1C(NC(=O)C2=CC=C(C(=O)N3CCC(C(=O)C4=CC=C(C)C=C4)CC3)N=C2)CCN(C1)CC1=CC=C(C#N)C=C1 Chemical compound C1C(NC(=O)C2=CC=C(C(=O)N3CCC(C(=O)C4=CC=C(C)C=C4)CC3)N=C2)CCN(C1)CC1=CC=C(C#N)C=C1 KGDGVGWNVIEHQL-UHFFFAOYSA-N 0.000 description 1
- KHKOALZGRAJSFA-UHFFFAOYSA-N CC(C)C1=CC=C(C=C1)N2CCN(CC2)C(=O)C3=CN=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC=C(C=C5)C#N Chemical compound CC(C)C1=CC=C(C=C1)N2CCN(CC2)C(=O)C3=CN=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC=C(C=C5)C#N KHKOALZGRAJSFA-UHFFFAOYSA-N 0.000 description 1
- ATXVRIMQWFAQOK-UHFFFAOYSA-N CC(C)C1=CC=C(C=C1)N2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4=CN=C(C=C4)OC5=CC=C(C=C5)C(=O)C Chemical compound CC(C)C1=CC=C(C=C1)N2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4=CN=C(C=C4)OC5=CC=C(C=C5)C(=O)C ATXVRIMQWFAQOK-UHFFFAOYSA-N 0.000 description 1
- JHTZDDUIDJQPJL-UHFFFAOYSA-N CC1=CC=C(C=C1)C(=O)C2CCN(CC2)C(=O)C3=CN=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC=C(C=C5)C#N Chemical compound CC1=CC=C(C=C1)C(=O)C2CCN(CC2)C(=O)C3=CN=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC=C(C=C5)C#N JHTZDDUIDJQPJL-UHFFFAOYSA-N 0.000 description 1
- IMOHABWBRHBSLW-UHFFFAOYSA-N CC1=CC=C(C=C1)C(=O)C2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4=CN=C(C=C4)OC5=CC=C(C=C5)F Chemical compound CC1=CC=C(C=C1)C(=O)C2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4=CN=C(C=C4)OC5=CC=C(C=C5)F IMOHABWBRHBSLW-UHFFFAOYSA-N 0.000 description 1
- ULVQTPRAEGEBBG-UHFFFAOYSA-N CC1=CC=C(C=C1)C(=O)C2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC=C(C=C5)F Chemical compound CC1=CC=C(C=C1)C(=O)C2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC=C(C=C5)F ULVQTPRAEGEBBG-UHFFFAOYSA-N 0.000 description 1
- XYCNAKIYNYYVAN-UHFFFAOYSA-N CC1=CC=C(C=C1)C(=O)C2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC=C(C=C5)N6CCCC6 Chemical compound CC1=CC=C(C=C1)C(=O)C2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC=C(C=C5)N6CCCC6 XYCNAKIYNYYVAN-UHFFFAOYSA-N 0.000 description 1
- NDAAPEZTNBMFSX-UHFFFAOYSA-N CC1=CC=C(C=C1)C(=O)C2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC=C(C=C5)OC Chemical compound CC1=CC=C(C=C1)C(=O)C2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC=C(C=C5)OC NDAAPEZTNBMFSX-UHFFFAOYSA-N 0.000 description 1
- NIJAFYOANGVJPO-UHFFFAOYSA-N CC1=CC=C(C=C1)N2CCN(CC2)C(=O)C3=CN=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC=C(C=C5)C#N Chemical compound CC1=CC=C(C=C1)N2CCN(CC2)C(=O)C3=CN=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC=C(C=C5)C#N NIJAFYOANGVJPO-UHFFFAOYSA-N 0.000 description 1
- YDHXJIHQYNMLIF-UHFFFAOYSA-N CC1=CC=C(C=C1)N2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4=CN=C(C=C4)OC5=CC=C(C=C5)C(=O)C Chemical compound CC1=CC=C(C=C1)N2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4=CN=C(C=C4)OC5=CC=C(C=C5)C(=O)C YDHXJIHQYNMLIF-UHFFFAOYSA-N 0.000 description 1
- PJSJDTHVWVECNP-UHFFFAOYSA-N CC1=CC=C(C=C1)OC2CCN(CC2)C(=O)C3=CN=C(C=C3)C(=O)NC4=CN=C(C=C4)OC5=CC=C(C=C5)C(=O)C Chemical compound CC1=CC=C(C=C1)OC2CCN(CC2)C(=O)C3=CN=C(C=C3)C(=O)NC4=CN=C(C=C4)OC5=CC=C(C=C5)C(=O)C PJSJDTHVWVECNP-UHFFFAOYSA-N 0.000 description 1
- LKRAGLNUAHXJNT-UHFFFAOYSA-N CC1=CC=C(C=C1)OC2CCN(CC2)C(=O)C3=CN=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC(=CC=C5)OC Chemical compound CC1=CC=C(C=C1)OC2CCN(CC2)C(=O)C3=CN=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC(=CC=C5)OC LKRAGLNUAHXJNT-UHFFFAOYSA-N 0.000 description 1
- FRTBKUDRDRDNQH-UHFFFAOYSA-N CC1=CC=C(C=C1)OC2CCN(CC2)C(=O)C3=CN=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC=C(C=C5)C#N Chemical compound CC1=CC=C(C=C1)OC2CCN(CC2)C(=O)C3=CN=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC=C(C=C5)C#N FRTBKUDRDRDNQH-UHFFFAOYSA-N 0.000 description 1
- HFCRTCMPAUPEJW-UHFFFAOYSA-N CC1=CC=C(C=C1)OC2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4=CN=C(C=C4)CC5=CC=C(C=C5)F Chemical compound CC1=CC=C(C=C1)OC2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4=CN=C(C=C4)CC5=CC=C(C=C5)F HFCRTCMPAUPEJW-UHFFFAOYSA-N 0.000 description 1
- PAIRWBQYWPIOKM-UHFFFAOYSA-N CC1=CC=C(C=C1)OC2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4=CN=C(C=C4)OC5=CC=C(C=C5)C(=O)C Chemical compound CC1=CC=C(C=C1)OC2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4=CN=C(C=C4)OC5=CC=C(C=C5)C(=O)C PAIRWBQYWPIOKM-UHFFFAOYSA-N 0.000 description 1
- WKVDROGTYQLCHC-UHFFFAOYSA-N CC1=CC=C(C=C1)OC2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4CCC(CC4)OC5=CC=C(C=C5)C#N Chemical compound CC1=CC=C(C=C1)OC2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4CCC(CC4)OC5=CC=C(C=C5)C#N WKVDROGTYQLCHC-UHFFFAOYSA-N 0.000 description 1
- XELPDCRJZXPXEC-UHFFFAOYSA-N CC1=CC=C(C=C1)OC2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC(=CC(=C5)F)F Chemical compound CC1=CC=C(C=C1)OC2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC(=CC(=C5)F)F XELPDCRJZXPXEC-UHFFFAOYSA-N 0.000 description 1
- SUIBOECFXUWNJD-UHFFFAOYSA-N CC1=CC=C(C=C1)OC2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC(=CC=C5)OC Chemical compound CC1=CC=C(C=C1)OC2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC(=CC=C5)OC SUIBOECFXUWNJD-UHFFFAOYSA-N 0.000 description 1
- PQDNQTAVIFKNLY-UHFFFAOYSA-N CC1=CC=C(C=C1)OC2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC=C(C=C5)C#N Chemical compound CC1=CC=C(C=C1)OC2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC=C(C=C5)C#N PQDNQTAVIFKNLY-UHFFFAOYSA-N 0.000 description 1
- UUZOPWSYPZJFBK-UHFFFAOYSA-N CC1=CC=C(C=C1)OC2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC=C(C=C5)F Chemical compound CC1=CC=C(C=C1)OC2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC=C(C=C5)F UUZOPWSYPZJFBK-UHFFFAOYSA-N 0.000 description 1
- GNPZRGSPKYRVQL-UHFFFAOYSA-N CC1=CC=C(C=C1)OC2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC=C(C=C5)OC Chemical compound CC1=CC=C(C=C1)OC2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC=C(C=C5)OC GNPZRGSPKYRVQL-UHFFFAOYSA-N 0.000 description 1
- RFYYTEWAEFWDKF-UHFFFAOYSA-N CC1=CC=C(C=C1)OC2CCN(CC2)C(=O)C3=NN=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC=C(C=C5)C#N Chemical compound CC1=CC=C(C=C1)OC2CCN(CC2)C(=O)C3=NN=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC=C(C=C5)C#N RFYYTEWAEFWDKF-UHFFFAOYSA-N 0.000 description 1
- HHGYWGZUFUZIJY-UHFFFAOYSA-N CCC1=CC=C(C=C1)C(=O)C2CCN(CC2)C(=O)C3=CN=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC=C(C=C5)C#N Chemical compound CCC1=CC=C(C=C1)C(=O)C2CCN(CC2)C(=O)C3=CN=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC=C(C=C5)C#N HHGYWGZUFUZIJY-UHFFFAOYSA-N 0.000 description 1
- OLOZIBNMGBLLJM-UHFFFAOYSA-N CNC1=C(C=CC(=C1)OC)OC2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC=C(C=C5)C#N Chemical compound CNC1=C(C=CC(=C1)OC)OC2CCN(CC2)C(=O)C3=NC=C(C=C3)C(=O)NC4CCN(CC4)CC5=CC=C(C=C5)C#N OLOZIBNMGBLLJM-UHFFFAOYSA-N 0.000 description 1
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical group [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 1
- 102000012437 Copper-Transporting ATPases Human genes 0.000 description 1
- 208000011231 Crohn disease Diseases 0.000 description 1
- 201000010374 Down Syndrome Diseases 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 208000024412 Friedreich ataxia Diseases 0.000 description 1
- 208000002972 Hepatolenticular Degeneration Diseases 0.000 description 1
- 208000023105 Huntington disease Diseases 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 description 1
- 206010058799 Mitochondrial encephalomyopathy Diseases 0.000 description 1
- LEUSDRGCPVXECX-FICMROCWSA-N N-[(3R)-1-[(4-cyanophenyl)methyl]-3-fluoropiperidin-4-yl]-6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2[C@@H](CN(CC=3C=CC(=CC=3)C#N)CC2)F)CC1 LEUSDRGCPVXECX-FICMROCWSA-N 0.000 description 1
- CKXPBSUKGATDRJ-SANMLTNESA-N N-[(3S)-1-[(4-cyanophenyl)methyl]pyrrolidin-3-yl]-5-[4-[(4-fluorophenyl)methyl]-3-oxopiperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound Fc1ccc(CN2CCN(CC2=O)C(=O)c2ccc(nc2)C(=O)N[C@H]2CCN(Cc3ccc(cc3)C#N)C2)cc1 CKXPBSUKGATDRJ-SANMLTNESA-N 0.000 description 1
- LEUSDRGCPVXECX-URLMMPGGSA-N N-[(3S,4R)-1-[(4-cyanophenyl)methyl]-3-fluoropiperidin-4-yl]-6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)N[C@H]2[C@H](CN(CC=3C=CC(=CC=3)C#N)CC2)F)CC1 LEUSDRGCPVXECX-URLMMPGGSA-N 0.000 description 1
- HWOSDYNCBXZMQP-WUFINQPMSA-N N-[(3S,4R)-3-fluoro-1-[[4-(trifluoromethoxy)phenyl]methyl]piperidin-4-yl]-6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)N[C@H]2[C@H](CN(CC=3C=CC(OC(F)(F)F)=CC=3)CC2)F)CC1 HWOSDYNCBXZMQP-WUFINQPMSA-N 0.000 description 1
- CGHXVKSEPXSOKT-UHFFFAOYSA-N N-[1-(4-cyanophenoxy)piperidin-4-yl]-6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound COc1ccc(cc1)C(=O)C1CCN(CC1)C(=O)c1ccc(cn1)C(=O)NC1CCN(CC1)Oc1ccc(cc1)C#N CGHXVKSEPXSOKT-UHFFFAOYSA-N 0.000 description 1
- PBWMNTCCVDFBFE-UHFFFAOYSA-N N-[1-(4-fluorophenoxy)piperidin-4-yl]-6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound COc1ccc(cc1)C(=O)C1CCN(CC1)C(=O)c1ccc(cn1)C(=O)NC1CCN(CC1)Oc1ccc(F)cc1 PBWMNTCCVDFBFE-UHFFFAOYSA-N 0.000 description 1
- AJYLLLGCOILHRH-UHFFFAOYSA-N N-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-6-[4-[4-(dimethylamino)benzoyl]piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound CN(C)c1ccc(cc1)C(=O)C1CCN(CC1)C(=O)c1ccc(cn1)C(=O)NC1CCN(Cc2ccc(cc2)C#N)CC1 AJYLLLGCOILHRH-UHFFFAOYSA-N 0.000 description 1
- ILMFTSMWOSIQRL-UHFFFAOYSA-N N-[4-(4-cyano-3-fluorophenoxy)cyclohexyl]-5-[4-(4-methoxyphenoxy)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound COc1ccc(OC2CCN(CC2)C(=O)c2ccc(nc2)C(=O)NC2CCC(CC2)Oc2ccc(C#N)c(F)c2)cc1 ILMFTSMWOSIQRL-UHFFFAOYSA-N 0.000 description 1
- FWSGCPSSGXJESZ-UHFFFAOYSA-N N-[4-(4-cyano-3-fluorophenoxy)cyclohexyl]-5-[4-[4-(trifluoromethyl)phenoxy]piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=C(C#N)C(F)=CC(OC2CCC(CC2)NC(=O)C=2N=CC(=CC=2)C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)C(F)(F)F)=C1 FWSGCPSSGXJESZ-UHFFFAOYSA-N 0.000 description 1
- DXFJCXIKMLXEJV-UHFFFAOYSA-N N-[4-(4-cyanophenoxy)cyclohexyl]-5-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCC(CC2)OC=2C=CC(=CC=2)C#N)CC1 DXFJCXIKMLXEJV-UHFFFAOYSA-N 0.000 description 1
- GIQKDCHBWREEQP-UHFFFAOYSA-N N-[4-(4-cyanophenoxy)cyclohexyl]-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCC(CC2)OC=2C=CC(=CC=2)C#N)CC1 GIQKDCHBWREEQP-UHFFFAOYSA-N 0.000 description 1
- QMWAQWPUELAOOP-UHFFFAOYSA-N N-[4-(4-cyanophenoxy)cyclohexyl]-5-[4-[4-(trifluoromethyl)phenoxy]piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(C(F)(F)F)=CC=C1OC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCC(CC2)OC=2C=CC(=CC=2)C#N)CC1 QMWAQWPUELAOOP-UHFFFAOYSA-N 0.000 description 1
- KNSGWXFUNINQIP-UHFFFAOYSA-N N-[4-(4-methoxyphenoxy)cyclohexyl]-5-[4-(4-methoxyphenoxy)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1OC1CCC(NC(=O)C=2N=CC(=CC=2)C(=O)N2CCC(CC2)OC=2C=CC(OC)=CC=2)CC1 KNSGWXFUNINQIP-UHFFFAOYSA-N 0.000 description 1
- QKTLBWHRMYOPPU-UHFFFAOYSA-N N-[4-(4-methoxyphenoxy)cyclohexyl]-5-[4-[4-(trifluoromethyl)phenoxy]piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1OC1CCC(NC(=O)C=2N=CC(=CC=2)C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)C(F)(F)F)CC1 QKTLBWHRMYOPPU-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- 206010033645 Pancreatitis Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010063837 Reperfusion injury Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 206010046851 Uveitis Diseases 0.000 description 1
- 208000018839 Wilson disease Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- CHWFYLUDMGYJQK-UHFFFAOYSA-N [1-[5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridin-2-yl]piperidin-4-yl]-(4-methoxyphenyl)methanone Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C=2N=CC(=CC=2)C(=O)N2CCN(CC=3C=CC(F)=CC=3)CC2)CC1 CHWFYLUDMGYJQK-UHFFFAOYSA-N 0.000 description 1
- SZJATISBSPFCJL-UHFFFAOYSA-N [4-[(4-fluorophenyl)methyl]piperazin-1-yl]-[6-(3-phenylanilino)pyridin-3-yl]methanone Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(NC=3C=C(C=CC=3)C=3C=CC=CC=3)=CC=2)CC1 SZJATISBSPFCJL-UHFFFAOYSA-N 0.000 description 1
- QSFRHVLXMAFXQR-UHFFFAOYSA-N [4-[(4-fluorophenyl)methyl]piperazin-1-yl]-[6-(3-phenylmethoxyphenyl)pyridin-3-yl]methanone Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C=2C=C(OCC=3C=CC=CC=3)C=CC=2)CC1 QSFRHVLXMAFXQR-UHFFFAOYSA-N 0.000 description 1
- SCZKOAZZRCYNFT-UHFFFAOYSA-N [4-[(4-fluorophenyl)methyl]piperazin-1-yl]-[6-(4-phenoxyanilino)pyridin-3-yl]methanone Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(NC=3C=CC(OC=4C=CC=CC=4)=CC=3)=CC=2)CC1 SCZKOAZZRCYNFT-UHFFFAOYSA-N 0.000 description 1
- LFRKRHVIDSBBJO-UHFFFAOYSA-N [4-[(4-fluorophenyl)methyl]piperazin-1-yl]-[6-(4-phenylmethoxyphenyl)pyridin-3-yl]methanone Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C=2C=CC(OCC=3C=CC=CC=3)=CC=2)CC1 LFRKRHVIDSBBJO-UHFFFAOYSA-N 0.000 description 1
- HOVNBOLMJBLKSZ-UHFFFAOYSA-N [4-[(4-fluorophenyl)methyl]piperazin-1-yl]-[6-(4-phenylpiperazine-1-carbonyl)pyridin-2-yl]methanone Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2N=C(C=CC=2)C(=O)N2CCN(CC2)C=2C=CC=CC=2)CC1 HOVNBOLMJBLKSZ-UHFFFAOYSA-N 0.000 description 1
- UKCFFODPBLWFIW-UHFFFAOYSA-N [4-[(4-fluorophenyl)methyl]piperazin-1-yl]-[6-[4-(2-phenylethyl)piperazine-1-carbonyl]pyridin-3-yl]methanone Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)N2CCN(CCC=3C=CC=CC=3)CC2)CC1 UKCFFODPBLWFIW-UHFFFAOYSA-N 0.000 description 1
- NLRIVKKELMUADS-UHFFFAOYSA-N [4-[(4-fluorophenyl)methyl]piperazin-1-yl]-[6-[4-[4-(trifluoromethyl)phenoxy]piperidin-1-yl]pyridin-3-yl]methanone Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)N2CCC(CC2)OC=2C=CC(=CC=2)C(F)(F)F)CC1 NLRIVKKELMUADS-UHFFFAOYSA-N 0.000 description 1
- VPTJAMUGKWOOJY-UHFFFAOYSA-N [4-[(4-fluorophenyl)methyl]piperazin-1-yl]-[6-[[1-[(4-fluorophenyl)methyl]pyrazol-4-yl]amino]pyridin-3-yl]methanone Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(NC3=CN(CC=4C=CC(F)=CC=4)N=C3)=CC=2)CC1 VPTJAMUGKWOOJY-UHFFFAOYSA-N 0.000 description 1
- PXCXFGLKFBBGMD-UHFFFAOYSA-N [6-(4-benzylanilino)pyridin-3-yl]-[4-[(4-fluorophenyl)methyl]piperazin-1-yl]methanone Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(NC=3C=CC(CC=4C=CC=CC=4)=CC=3)=CC=2)CC1 PXCXFGLKFBBGMD-UHFFFAOYSA-N 0.000 description 1
- HLMPLICAEPSBJM-UHFFFAOYSA-N [6-(4-benzylpiperazine-1-carbonyl)pyridin-3-yl]-(4-benzylpiperazin-1-yl)methanone Chemical compound C=1C=C(C(=O)N2CCN(CC=3C=CC=CC=3)CC2)N=CC=1C(=O)N(CC1)CCN1CC1=CC=CC=C1 HLMPLICAEPSBJM-UHFFFAOYSA-N 0.000 description 1
- DILDXNXKQQSZDE-UHFFFAOYSA-N [6-[4-(2-phenylethyl)piperazine-1-carbonyl]pyridin-3-yl]-(4-phenylpiperazin-1-yl)methanone Chemical compound C=1C=C(C(=O)N2CCN(CCC=3C=CC=CC=3)CC2)N=CC=1C(=O)N(CC1)CCN1C1=CC=CC=C1 DILDXNXKQQSZDE-UHFFFAOYSA-N 0.000 description 1
- WELVWANXLGVWPI-UHFFFAOYSA-N [6-[4-(2-phenylethyl)piperazine-1-carbonyl]pyridin-3-yl]-(4-propan-2-ylpiperazin-1-yl)methanone Chemical compound C1CN(C(C)C)CCN1C(=O)C1=CC=C(C(=O)N2CCN(CCC=3C=CC=CC=3)CC2)N=C1 WELVWANXLGVWPI-UHFFFAOYSA-N 0.000 description 1
- XIBAGROKRXXCJI-UHFFFAOYSA-N [6-[4-(2-phenylethyl)piperazine-1-carbonyl]pyridin-3-yl]-[4-(2-phenylethyl)piperazin-1-yl]methanone Chemical compound C=1C=C(C(=O)N2CCN(CCC=3C=CC=CC=3)CC2)N=CC=1C(=O)N(CC1)CCN1CCC1=CC=CC=C1 XIBAGROKRXXCJI-UHFFFAOYSA-N 0.000 description 1
- KXOMWEWZJKBODO-UHFFFAOYSA-N [6-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridin-2-yl]-[4-(2-phenylethyl)piperazin-1-yl]methanone Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2N=C(C=CC=2)C(=O)N2CCN(CCC=3C=CC=CC=3)CC2)CC1 KXOMWEWZJKBODO-UHFFFAOYSA-N 0.000 description 1
- ZCVDBEVZVHBBJC-UHFFFAOYSA-N [6-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridin-3-yl]-[4-[(4-fluorophenyl)methyl]piperazin-1-yl]methanone Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)N2CCN(CC=3C=CC(F)=CC=3)CC2)CC1 ZCVDBEVZVHBBJC-UHFFFAOYSA-N 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 201000009101 diabetic angiopathy Diseases 0.000 description 1
- 201000002249 diabetic peripheral angiopathy Diseases 0.000 description 1
- 208000037765 diseases and disorders Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- QBCOHMKIOZPEPA-UHFFFAOYSA-N ethyl 4-[1-[6-[[1-[(4-cyanophenyl)methyl]piperidin-4-yl]carbamoyl]pyridine-3-carbonyl]piperidin-4-yl]oxybenzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1OC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 QBCOHMKIOZPEPA-UHFFFAOYSA-N 0.000 description 1
- 230000037080 exercise endurance Effects 0.000 description 1
- RWTNPBWLLIMQHL-UHFFFAOYSA-N fexofenadine Chemical group C1=CC(C(C)(C(O)=O)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 RWTNPBWLLIMQHL-UHFFFAOYSA-N 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N formaldehyde Natural products O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 1
- 125000004438 haloalkoxy group Chemical group 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000001146 hypoxic effect Effects 0.000 description 1
- 125000002140 imidazol-4-yl group Chemical group [H]N1C([H])=NC([*])=C1[H] 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 208000012947 ischemia reperfusion injury Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 208000018191 liver inflammation Diseases 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 230000004898 mitochondrial function Effects 0.000 description 1
- 201000006938 muscular dystrophy Diseases 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- PGYYJEYPHRIKEA-UHFFFAOYSA-N n-(1-benzoylpiperidin-4-yl)-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC2)C(=O)C=2C=CC=CC=2)CC1 PGYYJEYPHRIKEA-UHFFFAOYSA-N 0.000 description 1
- SIUGKYLYXCIBJK-UHFFFAOYSA-N n-(1-benzylpiperidin-4-yl)-5-(3-phenoxyanilino)pyridine-2-carboxamide Chemical compound C=1C=C(NC=2C=C(OC=3C=CC=CC=3)C=CC=2)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=CC=C1 SIUGKYLYXCIBJK-UHFFFAOYSA-N 0.000 description 1
- ALWPRGJHZOZRBU-UHFFFAOYSA-N n-(1-benzylpiperidin-4-yl)-5-(3-phenylanilino)pyridine-2-carboxamide Chemical compound C=1C=C(NC=2C=C(C=CC=2)C=2C=CC=CC=2)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=CC=C1 ALWPRGJHZOZRBU-UHFFFAOYSA-N 0.000 description 1
- DBXTZCORMIZYNR-UHFFFAOYSA-N n-(1-benzylpiperidin-4-yl)-5-(4-phenoxyanilino)pyridine-2-carboxamide Chemical compound C=1C=C(NC=2C=CC(OC=3C=CC=CC=3)=CC=2)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=CC=C1 DBXTZCORMIZYNR-UHFFFAOYSA-N 0.000 description 1
- UHYHAUUNDGYPEZ-UHFFFAOYSA-N n-(1-benzylpiperidin-4-yl)-5-(4-phenylpiperazine-1-carbonyl)pyridine-2-carboxamide Chemical compound C=1C=C(C(=O)N2CCN(CC2)C=2C=CC=CC=2)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=CC=C1 UHYHAUUNDGYPEZ-UHFFFAOYSA-N 0.000 description 1
- LZSZSQKOWNJKPK-UHFFFAOYSA-N n-(1-benzylpiperidin-4-yl)-5-(4-pyridin-4-ylpiperazine-1-carbonyl)pyridine-2-carboxamide Chemical compound C=1C=C(C(=O)N2CCN(CC2)C=2C=CN=CC=2)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=CC=C1 LZSZSQKOWNJKPK-UHFFFAOYSA-N 0.000 description 1
- GWJLUAVBJOJUAI-UHFFFAOYSA-N n-(1-benzylpiperidin-4-yl)-5-[4-[(5-methyl-1,2-oxazol-3-yl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound O1C(C)=CC(CN2CCN(CC2)C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC=CC=3)CC2)=N1 GWJLUAVBJOJUAI-UHFFFAOYSA-N 0.000 description 1
- IVEYKDVYNMMLFY-UHFFFAOYSA-N n-(4-benzoylphenyl)-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=CC(=CC=2)C(=O)C=2C=CC=CC=2)CC1 IVEYKDVYNMMLFY-UHFFFAOYSA-N 0.000 description 1
- VRFSYYBIXZHSAS-UHFFFAOYSA-N n-(4-benzylphenyl)-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=CC(CC=3C=CC=CC=3)=CC=2)CC1 VRFSYYBIXZHSAS-UHFFFAOYSA-N 0.000 description 1
- MTYUQDCNXVHHAR-UHFFFAOYSA-N n-(4-bromophenyl)-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=CC(Br)=CC=2)CC1 MTYUQDCNXVHHAR-UHFFFAOYSA-N 0.000 description 1
- ZTMNZDLYLCMZAQ-HHHXNRCGSA-N n-[(3r)-1-[(4-cyanophenyl)methyl]pyrrolidin-3-yl]-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)N[C@H]2CN(CC=3C=CC(=CC=3)C#N)CC2)CC1 ZTMNZDLYLCMZAQ-HHHXNRCGSA-N 0.000 description 1
- LEUSDRGCPVXECX-FQLXRVMXSA-N n-[(3r,4r)-1-[(4-cyanophenyl)methyl]-3-fluoropiperidin-4-yl]-6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)N[C@H]2[C@@H](CN(CC=3C=CC(=CC=3)C#N)CC2)F)CC1 LEUSDRGCPVXECX-FQLXRVMXSA-N 0.000 description 1
- MPRAAOIVYGMJKJ-FIRIVFDPSA-N n-[(3r,4r)-3-fluoro-1-[(4-propan-2-yloxyphenyl)methyl]piperidin-4-yl]-6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)N[C@H]2[C@@H](CN(CC=3C=CC(OC(C)C)=CC=3)CC2)F)CC1 MPRAAOIVYGMJKJ-FIRIVFDPSA-N 0.000 description 1
- HWOSDYNCBXZMQP-VSGBNLITSA-N n-[(3r,4r)-3-fluoro-1-[[4-(trifluoromethoxy)phenyl]methyl]piperidin-4-yl]-6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)N[C@H]2[C@@H](CN(CC=3C=CC(OC(F)(F)F)=CC=3)CC2)F)CC1 HWOSDYNCBXZMQP-VSGBNLITSA-N 0.000 description 1
- GGMOGBNZFSCMDK-WUFINQPMSA-N n-[(3s,4r)-1-[(4-cyanophenyl)methyl]-3-fluoropiperidin-4-yl]-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C([C@@H]([C@@H](CC1)NC(=O)C=2N=CC(=CC=2)C(=O)N2CCN(CC=3C=CC(F)=CC=3)CC2)F)N1CC1=CC=C(C#N)C=C1 GGMOGBNZFSCMDK-WUFINQPMSA-N 0.000 description 1
- IGRUICVFLYEORO-UHFFFAOYSA-N n-[(4-cyanophenyl)methyl]-3-[5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridin-2-yl]benzamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C=2C=C(C=CC=2)C(=O)NCC=2C=CC(=CC=2)C#N)CC1 IGRUICVFLYEORO-UHFFFAOYSA-N 0.000 description 1
- PTFCCBDWBUWRTB-UHFFFAOYSA-N n-[(4-cyanophenyl)methyl]-4-[5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridin-2-yl]benzamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C=2C=CC(=CC=2)C(=O)NCC=2C=CC(=CC=2)C#N)CC1 PTFCCBDWBUWRTB-UHFFFAOYSA-N 0.000 description 1
- LTAMCBAUTUHECW-UHFFFAOYSA-N n-[(4-cyanophenyl)methyl]-4-[[5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridin-2-yl]amino]benzamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(NC=3C=CC(=CC=3)C(=O)NCC=3C=CC(=CC=3)C#N)=CC=2)CC1 LTAMCBAUTUHECW-UHFFFAOYSA-N 0.000 description 1
- AIJFSOPJUPPZAC-UHFFFAOYSA-N n-[1-(4-cyanobenzoyl)piperidin-4-yl]-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC2)C(=O)C=2C=CC(=CC=2)C#N)CC1 AIJFSOPJUPPZAC-UHFFFAOYSA-N 0.000 description 1
- MHLHQNWCMLCICH-UHFFFAOYSA-N n-[1-(4-cyanophenyl)piperidin-4-yl]-6-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC2)C=2C=CC(=CC=2)C#N)CC1 MHLHQNWCMLCICH-UHFFFAOYSA-N 0.000 description 1
- MJVVGQPISJDCKE-UHFFFAOYSA-N n-[1-(4-cyanophenyl)sulfonylpiperidin-4-yl]-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC2)S(=O)(=O)C=2C=CC(=CC=2)C#N)CC1 MJVVGQPISJDCKE-UHFFFAOYSA-N 0.000 description 1
- KUYAVZMMGBODBA-UHFFFAOYSA-N n-[1-(cyclohexanecarbonyl)piperidin-4-yl]-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC2)C(=O)C2CCCCC2)CC1 KUYAVZMMGBODBA-UHFFFAOYSA-N 0.000 description 1
- KCGHFTHUSALUFF-UHFFFAOYSA-N n-[1-(cyclohexylmethyl)piperidin-4-yl]-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC3CCCCC3)CC2)CC1 KCGHFTHUSALUFF-UHFFFAOYSA-N 0.000 description 1
- ADMHSPDKZAALOS-UHFFFAOYSA-N n-[1-[(3,5-difluorophenyl)methyl]piperidin-4-yl]-5-[3-(4-fluorophenoxy)pyrrolidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1OC1CN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=C(F)C=C(F)C=3)CC2)CC1 ADMHSPDKZAALOS-UHFFFAOYSA-N 0.000 description 1
- JTXPMIJNGKYFRZ-UHFFFAOYSA-N n-[1-[(3,5-difluorophenyl)methyl]piperidin-4-yl]-5-[3-[(4-fluorophenyl)methoxy]azetidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1COC1CN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=C(F)C=C(F)C=3)CC2)C1 JTXPMIJNGKYFRZ-UHFFFAOYSA-N 0.000 description 1
- QPCNUSNHBFCPAM-UHFFFAOYSA-N n-[1-[(3,5-difluorophenyl)methyl]piperidin-4-yl]-5-[4-(4-fluorophenoxy)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1OC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=C(F)C=C(F)C=3)CC2)CC1 QPCNUSNHBFCPAM-UHFFFAOYSA-N 0.000 description 1
- PQSYSUQLVSDROG-UHFFFAOYSA-N n-[1-[(3,5-difluorophenyl)methyl]piperidin-4-yl]-5-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=C(F)C=C(F)C=3)CC2)CC1 PQSYSUQLVSDROG-UHFFFAOYSA-N 0.000 description 1
- HIVGHAUHDXNYQB-UHFFFAOYSA-N n-[1-[(3,5-difluorophenyl)methyl]piperidin-4-yl]-5-[4-(4-methoxyphenoxy)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1OC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=C(F)C=C(F)C=3)CC2)CC1 HIVGHAUHDXNYQB-UHFFFAOYSA-N 0.000 description 1
- ZKEBDQJMFGPWQM-UHFFFAOYSA-N n-[1-[(3,5-difluorophenyl)methyl]piperidin-4-yl]-5-[4-(4-methylsulfonylphenoxy)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(S(=O)(=O)C)=CC=C1OC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=C(F)C=C(F)C=3)CC2)CC1 ZKEBDQJMFGPWQM-UHFFFAOYSA-N 0.000 description 1
- JEBWTTQATIZHGU-UHFFFAOYSA-N n-[1-[(3,5-difluorophenyl)methyl]piperidin-4-yl]-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=C(F)C=C(F)C=3)CC2)CC1 JEBWTTQATIZHGU-UHFFFAOYSA-N 0.000 description 1
- APBUQRJICSRSSS-UHFFFAOYSA-N n-[1-[(3,5-difluorophenyl)methyl]piperidin-4-yl]-5-[4-[4-(trifluoromethyl)phenoxy]piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound FC1=CC(F)=CC(CN2CCC(CC2)NC(=O)C=2N=CC(=CC=2)C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)C(F)(F)F)=C1 APBUQRJICSRSSS-UHFFFAOYSA-N 0.000 description 1
- HFGMPLDTNKSDKF-UHFFFAOYSA-N n-[1-[(3,5-difluorophenyl)methyl]piperidin-4-yl]-6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=C(F)C=C(F)C=3)CC2)CC1 HFGMPLDTNKSDKF-UHFFFAOYSA-N 0.000 description 1
- HVGXPVKSQJFBCU-UHFFFAOYSA-N n-[1-[(4-acetamidophenyl)methyl]piperidin-4-yl]-6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=CC(NC(C)=O)=CC=3)CC2)CC1 HVGXPVKSQJFBCU-UHFFFAOYSA-N 0.000 description 1
- RIUDPAORZJBEQE-UHFFFAOYSA-N n-[1-[(4-aminophenyl)methyl]piperidin-4-yl]-6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=CC(N)=CC=3)CC2)CC1 RIUDPAORZJBEQE-UHFFFAOYSA-N 0.000 description 1
- KAGDFRKVOFDGOY-UHFFFAOYSA-N n-[1-[(4-carbamoylphenyl)methyl]piperidin-4-yl]-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(C(=O)N)=CC=C1CN1CCC(NC(=O)C=2N=CC(=CC=2)C(=O)N2CCN(CC=3C=CC(F)=CC=3)CC2)CC1 KAGDFRKVOFDGOY-UHFFFAOYSA-N 0.000 description 1
- LQGICZMHJVYZGC-UHFFFAOYSA-N n-[1-[(4-cyano-3-fluorophenyl)methyl]piperidin-4-yl]-6-[4-(4-pyrrolidin-1-ylbenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=C(C#N)C(F)=CC(CN2CCC(CC2)NC(=O)C=2C=NC(=CC=2)C(=O)N2CCC(CC2)C(=O)C=2C=CC(=CC=2)N2CCCC2)=C1 LQGICZMHJVYZGC-UHFFFAOYSA-N 0.000 description 1
- GLKJXMSLKUEYGJ-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]-3,3-difluoropiperidin-4-yl]-6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2C(CN(CC=3C=CC(=CC=3)C#N)CC2)(F)F)CC1 GLKJXMSLKUEYGJ-UHFFFAOYSA-N 0.000 description 1
- XECSTZQZWRCGSO-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-(4-phenylanilino)pyridine-2-carboxamide Chemical compound C=1C=C(NC=2C=CC(=CC=2)C=2C=CC=CC=2)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 XECSTZQZWRCGSO-UHFFFAOYSA-N 0.000 description 1
- SXPSAQUONWUCPN-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-(4-propan-2-ylpiperazine-1-carbonyl)pyridine-2-carboxamide Chemical compound C1CN(C(C)C)CCN1C(=O)C1=CC=C(C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)N=C1 SXPSAQUONWUCPN-UHFFFAOYSA-N 0.000 description 1
- AHTSNSKNLLGNAL-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-(4-pyridin-4-yloxypiperidine-1-carbonyl)pyridine-2-carboxamide Chemical compound C=1C=C(C(=O)N2CCC(CC2)OC=2C=CN=CC=2)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 AHTSNSKNLLGNAL-UHFFFAOYSA-N 0.000 description 1
- XJFFGYUNDZFZOG-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-(piperazine-1-carbonyl)pyridine-2-carboxamide Chemical compound C=1C=C(C(=O)N2CCNCC2)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 XJFFGYUNDZFZOG-UHFFFAOYSA-N 0.000 description 1
- CQIGWVFBNAADFU-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[(1-phenylpiperidin-4-yl)amino]pyridine-2-carboxamide Chemical compound C=1C=C(NC2CCN(CC2)C=2C=CC=CC=2)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 CQIGWVFBNAADFU-UHFFFAOYSA-N 0.000 description 1
- RLJZRJSNAZYVPY-HHHXNRCGSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[(3r)-3-(4-fluorophenoxy)pyrrolidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1O[C@H]1CN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 RLJZRJSNAZYVPY-HHHXNRCGSA-N 0.000 description 1
- KABCVIPOCMQHMB-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[2-[(4-fluorophenyl)methyl]piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CC1N(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CCCC1 KABCVIPOCMQHMB-UHFFFAOYSA-N 0.000 description 1
- RSHRVHMHGAFLSZ-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[3-(3-methoxyphenoxy)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound COC1=CC=CC(OC2CN(CCC2)C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)=C1 RSHRVHMHGAFLSZ-UHFFFAOYSA-N 0.000 description 1
- RLJZRJSNAZYVPY-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[3-(4-fluorophenoxy)pyrrolidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1OC1CN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 RLJZRJSNAZYVPY-UHFFFAOYSA-N 0.000 description 1
- KFXYGIMFSTTWQR-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[3-(4-methoxyphenoxy)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1OC1CN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CCC1 KFXYGIMFSTTWQR-UHFFFAOYSA-N 0.000 description 1
- JUPFXDZHGLSJJR-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[3-[(4-fluorophenyl)methoxy]azetidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1COC1CN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)C1 JUPFXDZHGLSJJR-UHFFFAOYSA-N 0.000 description 1
- SWDLJAZQRMNAGX-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[3-[(4-fluorophenyl)methyl]piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CC1CN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CCC1 SWDLJAZQRMNAGX-UHFFFAOYSA-N 0.000 description 1
- BYANCVXDXHRQLT-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-(2,2-dimethylpropanoyl)piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1CN(C(=O)C(C)(C)C)CCN1C(=O)C1=CC=C(C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)N=C1 BYANCVXDXHRQLT-UHFFFAOYSA-N 0.000 description 1
- XRDMDDSSWUSOAX-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-(2,4-difluorobenzoyl)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound FC1=CC(F)=CC=C1C(=O)C1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 XRDMDDSSWUSOAX-UHFFFAOYSA-N 0.000 description 1
- NTZCHZCFSJZAQG-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-(2,4-difluorophenoxy)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound FC1=CC(F)=CC=C1OC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 NTZCHZCFSJZAQG-UHFFFAOYSA-N 0.000 description 1
- ANTKASWXMLJFBB-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-(2-phenylpropan-2-yl)piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C=1C=CC=CC=1C(C)(C)N(CC1)CCN1C(=O)C(C=N1)=CC=C1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 ANTKASWXMLJFBB-UHFFFAOYSA-N 0.000 description 1
- RVVFUTBGTJOJLC-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-(3,4-difluorobenzoyl)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=C(F)C(F)=CC=C1C(=O)C1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 RVVFUTBGTJOJLC-UHFFFAOYSA-N 0.000 description 1
- BUTSOOYTBYLGPV-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-(3,4-difluorophenoxy)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=C(F)C(F)=CC=C1OC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 BUTSOOYTBYLGPV-UHFFFAOYSA-N 0.000 description 1
- CWUZNYCHXNYQDR-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-(4-cyclopropylsulfonylphenyl)piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C=1C=C(C(=O)N2CCN(CC2)C=2C=CC(=CC=2)S(=O)(=O)C2CC2)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 CWUZNYCHXNYQDR-UHFFFAOYSA-N 0.000 description 1
- RXZOTKZCZZFCCH-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-(4-fluorobenzoyl)piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1C(=O)N1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 RXZOTKZCZZFCCH-UHFFFAOYSA-N 0.000 description 1
- QZCUYXGDXFPQEA-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-(4-fluorobenzoyl)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1C(=O)C1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 QZCUYXGDXFPQEA-UHFFFAOYSA-N 0.000 description 1
- KAPJCNOKYHCMQW-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-(4-fluorophenyl)piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1N1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 KAPJCNOKYHCMQW-UHFFFAOYSA-N 0.000 description 1
- MDZHPVWRGQFKCQ-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-(4-fluorophenyl)sulfonylpiperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1S(=O)(=O)N1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 MDZHPVWRGQFKCQ-UHFFFAOYSA-N 0.000 description 1
- WPGURWCGKIGDPP-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-(4-fluorophenyl)sulfonylpiperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1S(=O)(=O)C1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 WPGURWCGKIGDPP-UHFFFAOYSA-N 0.000 description 1
- LXDHLOOAVAFEJF-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-(4-methoxybenzoyl)piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)N1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 LXDHLOOAVAFEJF-UHFFFAOYSA-N 0.000 description 1
- HVAFECNXPDQFSX-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-(4-methoxybenzoyl)piperidin-1-yl]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 HVAFECNXPDQFSX-UHFFFAOYSA-N 0.000 description 1
- NPKHHIRWHYYJGW-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyrazine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=NC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 NPKHHIRWHYYJGW-UHFFFAOYSA-N 0.000 description 1
- POEZYVXOVVWICH-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 POEZYVXOVVWICH-UHFFFAOYSA-N 0.000 description 1
- AVWVDLCYEHDFRA-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-(4-methoxyphenyl)sulfonylpiperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1S(=O)(=O)N1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 AVWVDLCYEHDFRA-UHFFFAOYSA-N 0.000 description 1
- HQFKPRNNDOUANQ-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-(4-methylphenoxy)piperidine-1-carbonyl]pyrazine-2-carboxamide Chemical compound C1=CC(C)=CC=C1OC1CCN(C(=O)C=2N=CC(=NC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 HQFKPRNNDOUANQ-UHFFFAOYSA-N 0.000 description 1
- FCLDRVKLOOYCDQ-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-(4-methylsulfanylbenzoyl)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(SC)=CC=C1C(=O)C1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 FCLDRVKLOOYCDQ-UHFFFAOYSA-N 0.000 description 1
- WCBBIBOXLBNHOV-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-(4-morpholin-4-ylbenzoyl)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C=1C=C(C(=O)N2CCC(CC2)C(=O)C=2C=CC(=CC=2)N2CCOCC2)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 WCBBIBOXLBNHOV-UHFFFAOYSA-N 0.000 description 1
- HVWHBZWYBCRQOP-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-(4-pyrrolidin-1-ylbenzoyl)piperidine-1-carbonyl]pyrazine-2-carboxamide Chemical compound C=1N=C(C(=O)N2CCC(CC2)C(=O)C=2C=CC(=CC=2)N2CCCC2)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 HVWHBZWYBCRQOP-UHFFFAOYSA-N 0.000 description 1
- UXNBFMGMBOACEC-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-(4-pyrrolidin-1-ylbenzoyl)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C=1C=C(C(=O)N2CCC(CC2)C(=O)C=2C=CC(=CC=2)N2CCCC2)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 UXNBFMGMBOACEC-UHFFFAOYSA-N 0.000 description 1
- WFWVYMHDWSBWSD-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-(cyclohexanecarbonyl)piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C=1C=C(C(=O)N2CCN(CC2)C(=O)C2CCCCC2)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 WFWVYMHDWSBWSD-UHFFFAOYSA-N 0.000 description 1
- YJICAVIHOWJTJS-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-(cyclohexylmethyl)piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C=1C=C(C(=O)N2CCN(CC3CCCCC3)CC2)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 YJICAVIHOWJTJS-UHFFFAOYSA-N 0.000 description 1
- NMCSHUMJBBZUEI-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-(oxan-4-yl)piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C=1C=C(C(=O)N2CCN(CC2)C2CCOCC2)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 NMCSHUMJBBZUEI-UHFFFAOYSA-N 0.000 description 1
- RMUCYZDCFKRSNY-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-(pyridin-4-ylmethyl)piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C=1C=C(C(=O)N2CCN(CC=3C=CN=CC=3)CC2)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 RMUCYZDCFKRSNY-UHFFFAOYSA-N 0.000 description 1
- PXNMSZNSQODFJQ-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-[(3,5-difluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound FC1=CC(F)=CC(CN2CCN(CC2)C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)=C1 PXNMSZNSQODFJQ-UHFFFAOYSA-N 0.000 description 1
- XGUKVBQSHUARJJ-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-[(3-fluoro-4-methoxyphenyl)methyl]piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=C(F)C(OC)=CC=C1CC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 XGUKVBQSHUARJJ-UHFFFAOYSA-N 0.000 description 1
- SBPPXQVCQDZTHN-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-[(3-methoxyphenyl)methyl]piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound COC1=CC=CC(CC2CCN(CC2)C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)=C1 SBPPXQVCQDZTHN-UHFFFAOYSA-N 0.000 description 1
- WNLKAYDTKKISBN-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-[(4-fluorophenyl)-hydroxymethyl]piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C=1C=C(F)C=CC=1C(O)C(CC1)CCN1C(=O)C(C=N1)=CC=C1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 WNLKAYDTKKISBN-UHFFFAOYSA-N 0.000 description 1
- CCVJKVSSPUWIOG-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-[(4-fluorophenyl)methyl]-3,3-dimethylpiperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound CC1(C)CN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CCN1CC1=CC=C(F)C=C1 CCVJKVSSPUWIOG-UHFFFAOYSA-N 0.000 description 1
- NDMQOBJALHHUBI-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-[(4-fluorophenyl)methyl]piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 NDMQOBJALHHUBI-UHFFFAOYSA-N 0.000 description 1
- WPSUUXHDAQDYPG-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-[(4-methoxyphenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 WPSUUXHDAQDYPG-UHFFFAOYSA-N 0.000 description 1
- CXYVYGXMFQSTKH-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-[(4-methoxyphenyl)methyl]piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1CC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 CXYVYGXMFQSTKH-UHFFFAOYSA-N 0.000 description 1
- GAXYQFRRJQSHAN-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-[(4-methylphenyl)methyl]piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(C)=CC=C1CC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 GAXYQFRRJQSHAN-UHFFFAOYSA-N 0.000 description 1
- RGJWOFQNRMIXJW-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-[4-(2,2,2-trifluoroacetyl)phenyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(C(=O)C(F)(F)F)=CC=C1N1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 RGJWOFQNRMIXJW-UHFFFAOYSA-N 0.000 description 1
- YFJQTHWORCUTFF-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-[4-(4-methylpiperazin-1-yl)benzoyl]piperidine-1-carbonyl]pyrazine-2-carboxamide Chemical compound C1CN(C)CCN1C1=CC=C(C(=O)C2CCN(CC2)C(=O)C=2N=CC(=NC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)C=C1 YFJQTHWORCUTFF-UHFFFAOYSA-N 0.000 description 1
- CQUHOAICBBXVEG-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-[4-(4-methylpiperazin-1-yl)benzoyl]piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1CN(C)CCN1C1=CC=C(C(=O)C2CCN(CC2)C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)C=C1 CQUHOAICBBXVEG-UHFFFAOYSA-N 0.000 description 1
- SRJYEJPJELERDT-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-[4-(cyclopropanecarbonyl)phenyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C=1C=C(C(=O)N2CCN(CC2)C=2C=CC(=CC=2)C(=O)C2CC2)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 SRJYEJPJELERDT-UHFFFAOYSA-N 0.000 description 1
- HUYCPHYFJJCRHE-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-[4-(dimethylcarbamoyl)phenoxy]piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(C(=O)N(C)C)=CC=C1OC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 HUYCPHYFJJCRHE-UHFFFAOYSA-N 0.000 description 1
- BAQNKGBJRYOBKF-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-[4-(pentafluoro-$l^{6}-sulfanyl)phenoxy]piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(S(F)(F)(F)(F)F)=CC=C1OC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 BAQNKGBJRYOBKF-UHFFFAOYSA-N 0.000 description 1
- JHRNQZYMFIIVGE-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-[4-(trifluoromethyl)phenoxy]piperidin-1-yl]pyridine-2-carboxamide Chemical compound C1=CC(C(F)(F)F)=CC=C1OC1CCN(C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 JHRNQZYMFIIVGE-UHFFFAOYSA-N 0.000 description 1
- AFFMBBJVFRZUEW-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-[4-(trifluoromethyl)phenoxy]piperidine-1-carbonyl]pyrazine-2-carboxamide Chemical compound C1=CC(C(F)(F)F)=CC=C1OC1CCN(C(=O)C=2N=CC(=NC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 AFFMBBJVFRZUEW-UHFFFAOYSA-N 0.000 description 1
- SWFYJWRPKQUXJE-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-[4-(trifluoromethyl)phenoxy]piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(C(F)(F)F)=CC=C1OC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 SWFYJWRPKQUXJE-UHFFFAOYSA-N 0.000 description 1
- ZRFMAUMUQYAFKO-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-[4-(trifluoromethyl)phenyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(C(F)(F)F)=CC=C1N1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 ZRFMAUMUQYAFKO-UHFFFAOYSA-N 0.000 description 1
- CUGRGOQWDRJFLR-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-[4-(trifluoromethylsulfanyl)phenoxy]piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(SC(F)(F)F)=CC=C1OC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 CUGRGOQWDRJFLR-UHFFFAOYSA-N 0.000 description 1
- CIYOQUUILYLVDA-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-[4-(trifluoromethylsulfonyl)phenyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(S(=O)(=O)C(F)(F)F)=CC=C1N1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 CIYOQUUILYLVDA-UHFFFAOYSA-N 0.000 description 1
- FJNHSBVZTQFKEF-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-[fluoro-(4-fluorophenyl)methyl]piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C=1C=C(F)C=CC=1C(F)C(CC1)CCN1C(=O)C(C=N1)=CC=C1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 FJNHSBVZTQFKEF-UHFFFAOYSA-N 0.000 description 1
- WQUGCKCCOOBUNT-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[4-fluoro-4-(4-fluorobenzoyl)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1C(=O)C1(F)CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 WQUGCKCCOOBUNT-UHFFFAOYSA-N 0.000 description 1
- SXLNCLDXSZOPBZ-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[[1-(4-cyanophenyl)piperidin-4-yl]amino]pyridine-2-carboxamide Chemical compound C=1C=C(NC2CCN(CC2)C=2C=CC(=CC=2)C#N)C=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 SXLNCLDXSZOPBZ-UHFFFAOYSA-N 0.000 description 1
- WDIUOLAJMWXWDH-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[[1-(4-fluorophenyl)piperidin-4-yl]amino]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1N1CCC(NC=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 WDIUOLAJMWXWDH-UHFFFAOYSA-N 0.000 description 1
- KXVNZBABMIWAFP-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-5-[[1-(4-methoxyphenyl)piperidin-4-yl]amino]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1N1CCC(NC=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 KXVNZBABMIWAFP-UHFFFAOYSA-N 0.000 description 1
- CZGHJHFJDOKLEU-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-6-[4-(2,4-difluorobenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound FC1=CC(F)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 CZGHJHFJDOKLEU-UHFFFAOYSA-N 0.000 description 1
- CQZOSLVFDRPCFJ-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-6-[4-(2,4-difluorophenoxy)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound FC1=CC(F)=CC=C1OC1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 CQZOSLVFDRPCFJ-UHFFFAOYSA-N 0.000 description 1
- CINVMDLCMBUCQO-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-6-[4-(4-cyclopropylsulfonylphenoxy)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C=1C=C(C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)S(=O)(=O)C2CC2)N=CC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 CINVMDLCMBUCQO-UHFFFAOYSA-N 0.000 description 1
- JZZXYUGABUNNTJ-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-6-[4-(4-fluorophenyl)sulfonylpiperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(F)=CC=C1S(=O)(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 JZZXYUGABUNNTJ-UHFFFAOYSA-N 0.000 description 1
- PNQUXRANYGABJB-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-6-[4-(4-methoxy-2-nitrophenoxy)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound [O-][N+](=O)C1=CC(OC)=CC=C1OC1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 PNQUXRANYGABJB-UHFFFAOYSA-N 0.000 description 1
- UZPPXFTWQGIEIS-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-6-[4-(4-methoxybenzoyl)piperidin-1-yl]pyridazine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C=2N=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 UZPPXFTWQGIEIS-UHFFFAOYSA-N 0.000 description 1
- FRYJAPPODQHJRU-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]-n-methylpyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)N(C)C2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 FRYJAPPODQHJRU-UHFFFAOYSA-N 0.000 description 1
- ZLENIQODLNSTCZ-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridazine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 ZLENIQODLNSTCZ-UHFFFAOYSA-N 0.000 description 1
- JKGJLUCJLNJXKG-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 JKGJLUCJLNJXKG-UHFFFAOYSA-N 0.000 description 1
- DSEUJSHMFHEHFZ-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-6-[4-(4-nitrophenoxy)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC([N+](=O)[O-])=CC=C1OC1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 DSEUJSHMFHEHFZ-UHFFFAOYSA-N 0.000 description 1
- JHDUODWCMKEUJW-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-6-[4-(4-pyrrolidin-1-ylbenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C=1C=C(C(=O)N2CCC(CC2)C(=O)C=2C=CC(=CC=2)N2CCCC2)N=CC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 JHDUODWCMKEUJW-UHFFFAOYSA-N 0.000 description 1
- PDHJZIQJMYUJNZ-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-6-[4-[(4-fluorophenyl)methyl]piperazin-1-yl]pyridazine-3-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C=2N=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 PDHJZIQJMYUJNZ-UHFFFAOYSA-N 0.000 description 1
- USKHWBFFPMZFMQ-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-6-[4-[2-(dimethylamino)-4-methoxyphenoxy]piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound CN(C)C1=CC(OC)=CC=C1OC1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 USKHWBFFPMZFMQ-UHFFFAOYSA-N 0.000 description 1
- DNOOJFBSTXDBIH-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-6-[4-[4-(4-methylpiperazin-1-yl)benzoyl]piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1CN(C)CCN1C1=CC=C(C(=O)C2CCN(CC2)C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)C=C1 DNOOJFBSTXDBIH-UHFFFAOYSA-N 0.000 description 1
- MPYZAJHIMPJCAB-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-6-[4-[4-(cyclopropanecarbonylamino)phenoxy]piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1CC1C(=O)NC(C=C1)=CC=C1OC(CC1)CCN1C(=O)C(N=C1)=CC=C1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 MPYZAJHIMPJCAB-UHFFFAOYSA-N 0.000 description 1
- CLJBRWCXTFMREC-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-6-[4-[4-(cyclopropylsulfonylamino)phenoxy]piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C=1C=C(C(=O)N2CCC(CC2)OC=2C=CC(NS(=O)(=O)C3CC3)=CC=2)N=CC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 CLJBRWCXTFMREC-UHFFFAOYSA-N 0.000 description 1
- GJMRQEGEEYASHD-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-6-[4-[4-(methanesulfonamido)phenoxy]piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(NS(=O)(=O)C)=CC=C1OC1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 GJMRQEGEEYASHD-UHFFFAOYSA-N 0.000 description 1
- YQNDTFLKFFIKOY-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-6-[4-[4-(pentafluoro-$l^{6}-sulfanyl)phenoxy]piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(S(F)(F)(F)(F)F)=CC=C1OC1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 YQNDTFLKFFIKOY-UHFFFAOYSA-N 0.000 description 1
- YTSTYPROPVLXLB-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-6-[4-[4-(trifluoromethyl)phenoxy]piperidin-1-yl]pyridazine-3-carboxamide Chemical compound C1=CC(C(F)(F)F)=CC=C1OC1CCN(C=2N=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 YTSTYPROPVLXLB-UHFFFAOYSA-N 0.000 description 1
- PKZHINNMONLOBK-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-6-[4-[4-(trifluoromethylsulfanyl)phenoxy]piperidine-1-carbonyl]pyridazine-3-carboxamide Chemical compound C1=CC(SC(F)(F)F)=CC=C1OC1CCN(C(=O)C=2N=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 PKZHINNMONLOBK-UHFFFAOYSA-N 0.000 description 1
- XVUVHIMZDREIIH-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]-6-[4-[4-(trifluoromethylsulfonyl)phenoxy]piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(S(=O)(=O)C(F)(F)F)=CC=C1OC1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C#N)CC2)CC1 XVUVHIMZDREIIH-UHFFFAOYSA-N 0.000 description 1
- JPHNAIFCKPLXEH-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]piperidin-4-yl]pyridine-2-carboxamide Chemical compound C=1C=CC=NC=1C(=O)NC(CC1)CCN1CC1=CC=C(C#N)C=C1 JPHNAIFCKPLXEH-UHFFFAOYSA-N 0.000 description 1
- RJDFHCCYYFFSBE-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]pyrazol-3-yl]-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2=NN(CC=3C=CC(=CC=3)C#N)C=C2)CC1 RJDFHCCYYFFSBE-UHFFFAOYSA-N 0.000 description 1
- NFOUIFJMANKDPS-UHFFFAOYSA-N n-[1-[(4-cyanophenyl)methyl]pyrazol-4-yl]-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2=CN(CC=3C=CC(=CC=3)C#N)N=C2)CC1 NFOUIFJMANKDPS-UHFFFAOYSA-N 0.000 description 1
- MYKBCPMYGPOKII-UHFFFAOYSA-N n-[1-[(4-fluoro-3-methylphenyl)methyl]piperidin-4-yl]-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=C(F)C(C)=CC(CN2CCC(CC2)NC(=O)C=2N=CC(=CC=2)C(=O)N2CCN(CC=3C=CC(F)=CC=3)CC2)=C1 MYKBCPMYGPOKII-UHFFFAOYSA-N 0.000 description 1
- HMMQLGQVAFWIOP-UHFFFAOYSA-N n-[1-[(4-fluorophenyl)methyl]piperidin-4-yl]-5-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(F)=CC=3)CC2)CC1 HMMQLGQVAFWIOP-UHFFFAOYSA-N 0.000 description 1
- WETBWPNUDSHYAH-UHFFFAOYSA-N n-[1-[(4-fluorophenyl)methyl]piperidin-4-yl]-5-[4-(4-methoxyphenoxy)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1OC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(F)=CC=3)CC2)CC1 WETBWPNUDSHYAH-UHFFFAOYSA-N 0.000 description 1
- LNDMBSSQDKPZBK-UHFFFAOYSA-N n-[1-[(4-fluorophenyl)methyl]piperidin-4-yl]-5-[4-(4-methylbenzoyl)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(C)=CC=C1C(=O)C1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(F)=CC=3)CC2)CC1 LNDMBSSQDKPZBK-UHFFFAOYSA-N 0.000 description 1
- UWFMRHLPQYNROO-UHFFFAOYSA-N n-[1-[(4-fluorophenyl)methyl]piperidin-4-yl]-5-[4-(4-methylphenoxy)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(C)=CC=C1OC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(F)=CC=3)CC2)CC1 UWFMRHLPQYNROO-UHFFFAOYSA-N 0.000 description 1
- RVROKBCZVIZYLZ-UHFFFAOYSA-N n-[1-[(4-fluorophenyl)methyl]piperidin-4-yl]-5-[4-[4-(trifluoromethyl)phenoxy]piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCC(NC(=O)C=2N=CC(=CC=2)C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)C(F)(F)F)CC1 RVROKBCZVIZYLZ-UHFFFAOYSA-N 0.000 description 1
- KNIWBJVPMSYDST-UHFFFAOYSA-N n-[1-[(4-fluorophenyl)methyl]piperidin-4-yl]-6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=CC(F)=CC=3)CC2)CC1 KNIWBJVPMSYDST-UHFFFAOYSA-N 0.000 description 1
- INGGFDWTZNSBPY-UHFFFAOYSA-N n-[1-[(4-fluorophenyl)methyl]piperidin-4-yl]-6-[4-(4-pyrrolidin-1-ylbenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCC(NC(=O)C=2C=NC(=CC=2)C(=O)N2CCC(CC2)C(=O)C=2C=CC(=CC=2)N2CCCC2)CC1 INGGFDWTZNSBPY-UHFFFAOYSA-N 0.000 description 1
- RMZUHPQXWRXPOP-UHFFFAOYSA-N n-[1-[(4-methoxyphenyl)methyl]piperidin-4-yl]-5-[4-(4-methylphenoxy)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1CN1CCC(NC(=O)C=2N=CC(=CC=2)C(=O)N2CCC(CC2)OC=2C=CC(C)=CC=2)CC1 RMZUHPQXWRXPOP-UHFFFAOYSA-N 0.000 description 1
- LLRSNVNZYTWKPN-UHFFFAOYSA-N n-[1-[(4-methoxyphenyl)methyl]piperidin-4-yl]-6-[4-(4-pyrrolidin-1-ylbenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1CN1CCC(NC(=O)C=2C=NC(=CC=2)C(=O)N2CCC(CC2)C(=O)C=2C=CC(=CC=2)N2CCCC2)CC1 LLRSNVNZYTWKPN-UHFFFAOYSA-N 0.000 description 1
- MZWKXTIWRUKNLP-UHFFFAOYSA-N n-[1-[(4-methoxyphenyl)methyl]piperidin-4-yl]-6-[4-[4-(pentafluoro-$l^{6}-sulfanyl)phenoxy]piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1CN1CCC(NC(=O)C=2C=NC(=CC=2)C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)S(F)(F)(F)(F)F)CC1 MZWKXTIWRUKNLP-UHFFFAOYSA-N 0.000 description 1
- HUMCBAOVNNNRNA-UHFFFAOYSA-N n-[1-[(4-propan-2-yloxyphenyl)methyl]piperidin-4-yl]-6-[4-(4-pyrrolidin-1-ylbenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(OC(C)C)=CC=C1CN1CCC(NC(=O)C=2C=NC(=CC=2)C(=O)N2CCC(CC2)C(=O)C=2C=CC(=CC=2)N2CCCC2)CC1 HUMCBAOVNNNRNA-UHFFFAOYSA-N 0.000 description 1
- PJUPLDXIIBQNBZ-UHFFFAOYSA-N n-[1-[2-(4-cyanophenyl)propan-2-yl]piperidin-4-yl]-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C=1C=C(C#N)C=CC=1C(C)(C)N(CC1)CCC1NC(=O)C(N=C1)=CC=C1C(=O)N(CC1)CCN1CC1=CC=C(F)C=C1 PJUPLDXIIBQNBZ-UHFFFAOYSA-N 0.000 description 1
- MJFMCJRNWDTCIF-UHFFFAOYSA-N n-[1-[[4-(dimethylcarbamoyl)phenyl]methyl]piperidin-4-yl]-6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCN(CC=3C=CC(=CC=3)C(=O)N(C)C)CC2)CC1 MJFMCJRNWDTCIF-UHFFFAOYSA-N 0.000 description 1
- HVUHUGNDUZGZJI-NVVQJRFUSA-N n-[1-[[4-[3-[2-[2-[2-[5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]ethoxy]ethoxy]ethoxy]propanoylamino]phenyl]methyl]piperidin-4-yl]-5-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCN(CC=3C=CC(NC(=O)CCOCCOCCOCCNC(=O)CCCC[C@H]4[C@H]5NC(=O)N[C@H]5CS4)=CC=3)CC2)CC1 HVUHUGNDUZGZJI-NVVQJRFUSA-N 0.000 description 1
- MLGAAABCCVIOEF-UHFFFAOYSA-N n-[2-(4-fluorophenoxy)ethyl]-5-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NCCOC=2C=CC(F)=CC=2)CC1 MLGAAABCCVIOEF-UHFFFAOYSA-N 0.000 description 1
- BIPLDIXMEWFTMU-UHFFFAOYSA-N n-[2-[(4-cyanophenyl)methyl]-3,4-dihydro-1h-isoquinolin-7-yl]-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=C3CN(CC=4C=CC(=CC=4)C#N)CCC3=CC=2)CC1 BIPLDIXMEWFTMU-UHFFFAOYSA-N 0.000 description 1
- WBQCMGADTQIKRW-UHFFFAOYSA-N n-[4-(3,5-difluorophenoxy)cyclohexyl]-5-[4-(4-fluorophenoxy)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1OC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCC(CC2)OC=2C=C(F)C=C(F)C=2)CC1 WBQCMGADTQIKRW-UHFFFAOYSA-N 0.000 description 1
- WUUYOPINRPLTPV-UHFFFAOYSA-N n-[4-(3,5-difluorophenoxy)cyclohexyl]-5-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCC(CC2)OC=2C=C(F)C=C(F)C=2)CC1 WUUYOPINRPLTPV-UHFFFAOYSA-N 0.000 description 1
- ZGVPWOWZROQALT-UHFFFAOYSA-N n-[4-(3-cyanophenoxy)phenyl]-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=CC(OC=3C=C(C=CC=3)C#N)=CC=2)CC1 ZGVPWOWZROQALT-UHFFFAOYSA-N 0.000 description 1
- GVARIDOMGKXGSD-UHFFFAOYSA-N n-[4-(3-cyanophenyl)phenyl]-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=CC(=CC=2)C=2C=C(C=CC=2)C#N)CC1 GVARIDOMGKXGSD-UHFFFAOYSA-N 0.000 description 1
- AFHGWQBLKGCROK-UHFFFAOYSA-N n-[4-(3-fluorophenoxy)phenyl]-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=CC(OC=3C=C(F)C=CC=3)=CC=2)CC1 AFHGWQBLKGCROK-UHFFFAOYSA-N 0.000 description 1
- RRLULESDYPQECY-YTZIBCIGSA-N n-[4-(4-cyanophenoxy)cyclohexyl]-5-[(3s)-3-(4-fluorophenoxy)pyrrolidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1O[C@@H]1CN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCC(CC2)OC=2C=CC(=CC=2)C#N)CC1 RRLULESDYPQECY-YTZIBCIGSA-N 0.000 description 1
- QXYDKUCICQMFKB-UHFFFAOYSA-N n-[4-(4-cyanophenoxy)cyclohexyl]-6-[4-(4-cyanophenoxy)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C=1C=C(C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)C#N)N=CC=1C(=O)NC(CC1)CCC1OC1=CC=C(C#N)C=C1 QXYDKUCICQMFKB-UHFFFAOYSA-N 0.000 description 1
- PWNFGRQMNJTNJN-UHFFFAOYSA-N n-[4-(4-cyanophenoxy)cyclohexyl]-6-[4-(4-pyrrolidin-1-ylbenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C=1C=C(C(=O)N2CCC(CC2)C(=O)C=2C=CC(=CC=2)N2CCCC2)N=CC=1C(=O)NC(CC1)CCC1OC1=CC=C(C#N)C=C1 PWNFGRQMNJTNJN-UHFFFAOYSA-N 0.000 description 1
- QMTWAPVKHUNKFZ-UHFFFAOYSA-N n-[4-(4-cyanophenoxy)cyclohexyl]-6-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC2CCC(CC2)OC=2C=CC(=CC=2)C#N)CC1 QMTWAPVKHUNKFZ-UHFFFAOYSA-N 0.000 description 1
- JKWVHOJBLXODFV-UHFFFAOYSA-N n-[4-(4-cyanophenoxy)cyclohexyl]-6-[4-[3-(cyclopropanecarbonylamino)phenoxy]piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1CC1C(=O)NC(C=1)=CC=CC=1OC(CC1)CCN1C(=O)C(N=C1)=CC=C1C(=O)NC(CC1)CCC1OC1=CC=C(C#N)C=C1 JKWVHOJBLXODFV-UHFFFAOYSA-N 0.000 description 1
- RANWOMLEXKWTRY-UHFFFAOYSA-N n-[4-(4-cyanophenoxy)phenyl]-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=CC(OC=3C=CC(=CC=3)C#N)=CC=2)CC1 RANWOMLEXKWTRY-UHFFFAOYSA-N 0.000 description 1
- XSUMTXIVYVXHQF-UHFFFAOYSA-N n-[4-(4-cyanophenyl)phenyl]-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=CC(=CC=2)C=2C=CC(=CC=2)C#N)CC1 XSUMTXIVYVXHQF-UHFFFAOYSA-N 0.000 description 1
- VGTANERTDXIGKZ-UHFFFAOYSA-N n-[4-(4-fluorophenoxy)cyclohexyl]-5-[4-(4-fluorophenoxy)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1OC1CCC(NC(=O)C=2N=CC(=CC=2)C(=O)N2CCC(CC2)OC=2C=CC(F)=CC=2)CC1 VGTANERTDXIGKZ-UHFFFAOYSA-N 0.000 description 1
- DDIKEHGCFSSELH-UHFFFAOYSA-N n-[4-(4-fluorophenoxy)cyclohexyl]-5-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC2CCC(CC2)OC=2C=CC(F)=CC=2)CC1 DDIKEHGCFSSELH-UHFFFAOYSA-N 0.000 description 1
- NOIUJGNQSASNRI-UHFFFAOYSA-N n-[4-(4-fluorophenoxy)phenyl]-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=CC(OC=3C=CC(F)=CC=3)=CC=2)CC1 NOIUJGNQSASNRI-UHFFFAOYSA-N 0.000 description 1
- DDXGSXLONGRSHS-UHFFFAOYSA-N n-[4-[(4-cyanophenyl)methyl]cyclohexyl]-6-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2N=C(C=CC=2)C(=O)NC2CCC(CC=3C=CC(=CC=3)C#N)CC2)CC1 DDXGSXLONGRSHS-UHFFFAOYSA-N 0.000 description 1
- BPUSTKQLALECFR-UHFFFAOYSA-N n-[4-[(4-cyanophenyl)methylcarbamoyl]phenyl]-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=CC(=CC=2)C(=O)NCC=2C=CC(=CC=2)C#N)CC1 BPUSTKQLALECFR-UHFFFAOYSA-N 0.000 description 1
- OWQAWPLCNSFMKM-UHFFFAOYSA-N n-[5-(4-cyanophenoxy)pyridin-2-yl]-6-[4-(2,4-difluorobenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound FC1=CC(F)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC=2N=CC(OC=3C=CC(=CC=3)C#N)=CC=2)CC1 OWQAWPLCNSFMKM-UHFFFAOYSA-N 0.000 description 1
- MHVPPJHUAXVIGF-UHFFFAOYSA-N n-[5-(4-cyanophenoxy)pyridin-2-yl]-6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC=2N=CC(OC=3C=CC(=CC=3)C#N)=CC=2)CC1 MHVPPJHUAXVIGF-UHFFFAOYSA-N 0.000 description 1
- RVMRUZKLKWZPBU-UHFFFAOYSA-N n-[5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridin-2-yl]-4-phenylbenzamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(NC(=O)C=3C=CC(=CC=3)C=3C=CC=CC=3)=CC=2)CC1 RVMRUZKLKWZPBU-UHFFFAOYSA-N 0.000 description 1
- ASBBFNPPGCMMTH-UHFFFAOYSA-N n-[6-(3-cyanophenoxy)pyridin-3-yl]-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=NC(OC=3C=C(C=CC=3)C#N)=CC=2)CC1 ASBBFNPPGCMMTH-UHFFFAOYSA-N 0.000 description 1
- GKRIJBBPXCVYRF-UHFFFAOYSA-N n-[6-(4-acetylphenoxy)pyridin-3-yl]-6-[4-(2,4-difluorobenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(C(=O)C)=CC=C1OC(N=C1)=CC=C1NC(=O)C1=CC=C(C(=O)N2CCC(CC2)C(=O)C=2C(=CC(F)=CC=2)F)N=C1 GKRIJBBPXCVYRF-UHFFFAOYSA-N 0.000 description 1
- MAJDJUWLOQSGFM-UHFFFAOYSA-N n-[6-(4-acetylphenoxy)pyridin-3-yl]-6-[4-(4-cyclopropylsulfonylphenoxy)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(C(=O)C)=CC=C1OC(N=C1)=CC=C1NC(=O)C1=CC=C(C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)S(=O)(=O)C2CC2)N=C1 MAJDJUWLOQSGFM-UHFFFAOYSA-N 0.000 description 1
- NWALXLHJGKSUHI-UHFFFAOYSA-N n-[6-(4-acetylphenoxy)pyridin-3-yl]-6-[4-(4-fluorophenyl)sulfonylpiperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(C(=O)C)=CC=C1OC(N=C1)=CC=C1NC(=O)C1=CC=C(C(=O)N2CCC(CC2)S(=O)(=O)C=2C=CC(F)=CC=2)N=C1 NWALXLHJGKSUHI-UHFFFAOYSA-N 0.000 description 1
- GVYSRPMXFBVISQ-UHFFFAOYSA-N n-[6-(4-acetylphenoxy)pyridin-3-yl]-6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC=2C=NC(OC=3C=CC(=CC=3)C(C)=O)=CC=2)CC1 GVYSRPMXFBVISQ-UHFFFAOYSA-N 0.000 description 1
- UUWVSSXXHKEBGA-UHFFFAOYSA-N n-[6-(4-acetylphenoxy)pyridin-3-yl]-6-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(C(=O)C)=CC=C1OC(N=C1)=CC=C1NC(=O)C1=CC=C(C(=O)N2CCN(CC=3C=CC(F)=CC=3)CC2)N=C1 UUWVSSXXHKEBGA-UHFFFAOYSA-N 0.000 description 1
- IDAXHXKLJMZMTG-UHFFFAOYSA-N n-[6-(4-acetylphenoxy)pyridin-3-yl]-6-[4-[4-(dimethylcarbamoyl)phenoxy]piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(C(=O)N(C)C)=CC=C1OC1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC=2C=NC(OC=3C=CC(=CC=3)C(C)=O)=CC=2)CC1 IDAXHXKLJMZMTG-UHFFFAOYSA-N 0.000 description 1
- FGKOOCQTYBWAPY-UHFFFAOYSA-N n-[6-(4-cyanophenoxy)-2-methylpyridin-3-yl]-6-[4-(2,4-difluorobenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C=1C=C(NC(=O)C=2C=NC(=CC=2)C(=O)N2CCC(CC2)C(=O)C=2C(=CC(F)=CC=2)F)C(C)=NC=1OC1=CC=C(C#N)C=C1 FGKOOCQTYBWAPY-UHFFFAOYSA-N 0.000 description 1
- YOZDAUSMDOLDJM-UHFFFAOYSA-N n-[6-(4-cyanophenoxy)-2-methylpyridin-3-yl]-6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC=2C(=NC(OC=3C=CC(=CC=3)C#N)=CC=2)C)CC1 YOZDAUSMDOLDJM-UHFFFAOYSA-N 0.000 description 1
- SXCVHBDVDRBZIC-UHFFFAOYSA-N n-[6-(4-cyanophenoxy)pyridin-3-yl]-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=NC(OC=3C=CC(=CC=3)C#N)=CC=2)CC1 SXCVHBDVDRBZIC-UHFFFAOYSA-N 0.000 description 1
- MBGUZCQMFZFQCG-UHFFFAOYSA-N n-[6-(4-cyanophenoxy)pyridin-3-yl]-6-[4-(2,4-difluorobenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound FC1=CC(F)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC=2C=NC(OC=3C=CC(=CC=3)C#N)=CC=2)CC1 MBGUZCQMFZFQCG-UHFFFAOYSA-N 0.000 description 1
- ZPVFVTXUAVUJPB-UHFFFAOYSA-N n-[6-(4-cyanophenoxy)pyridin-3-yl]-6-[4-(4-fluorophenyl)sulfonylpiperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(F)=CC=C1S(=O)(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC=2C=NC(OC=3C=CC(=CC=3)C#N)=CC=2)CC1 ZPVFVTXUAVUJPB-UHFFFAOYSA-N 0.000 description 1
- NMTSURTYCYXFAT-UHFFFAOYSA-N n-[6-(4-cyanophenoxy)pyridin-3-yl]-6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC=2C=NC(OC=3C=CC(=CC=3)C#N)=CC=2)CC1 NMTSURTYCYXFAT-UHFFFAOYSA-N 0.000 description 1
- ZZTBEWMJLPGORM-UHFFFAOYSA-N n-[6-(4-cyanophenoxy)pyridin-3-yl]-6-[4-(4-methylsulfonylphenoxy)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(S(=O)(=O)C)=CC=C1OC1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC=2C=NC(OC=3C=CC(=CC=3)C#N)=CC=2)CC1 ZZTBEWMJLPGORM-UHFFFAOYSA-N 0.000 description 1
- LFRYTBJZABLZSQ-UHFFFAOYSA-N n-[6-(4-cyanophenoxy)pyridin-3-yl]-6-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC=2C=NC(OC=3C=CC(=CC=3)C#N)=CC=2)CC1 LFRYTBJZABLZSQ-UHFFFAOYSA-N 0.000 description 1
- GEWONQLQWOVJJA-UHFFFAOYSA-N n-[6-(4-cyanophenoxy)pyridin-3-yl]-6-[4-[4-(pentafluoro-$l^{6}-sulfanyl)phenoxy]piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(S(F)(F)(F)(F)F)=CC=C1OC1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC=2C=NC(OC=3C=CC(=CC=3)C#N)=CC=2)CC1 GEWONQLQWOVJJA-UHFFFAOYSA-N 0.000 description 1
- LFVWKMPSGSNUPO-UHFFFAOYSA-N n-[6-(4-fluorophenoxy)pyridin-3-yl]-5-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=NC(OC=3C=CC(F)=CC=3)=CC=2)CC1 LFVWKMPSGSNUPO-UHFFFAOYSA-N 0.000 description 1
- KQQWQTMZKXZLSA-UHFFFAOYSA-N n-[6-(4-fluorophenoxy)pyridin-3-yl]-5-[4-(4-methylbenzoyl)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(C)=CC=C1C(=O)C1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=NC(OC=3C=CC(F)=CC=3)=CC=2)CC1 KQQWQTMZKXZLSA-UHFFFAOYSA-N 0.000 description 1
- YYUWHTNNPRUOTQ-UHFFFAOYSA-N n-[6-(4-fluorophenoxy)pyridin-3-yl]-5-[4-(4-methylphenoxy)piperidine-1-carbonyl]pyrazine-2-carboxamide Chemical compound C1=CC(C)=CC=C1OC1CCN(C(=O)C=2N=CC(=NC=2)C(=O)NC=2C=NC(OC=3C=CC(F)=CC=3)=CC=2)CC1 YYUWHTNNPRUOTQ-UHFFFAOYSA-N 0.000 description 1
- BNYMQAJOSJXUFB-UHFFFAOYSA-N n-[6-(4-fluorophenoxy)pyridin-3-yl]-5-[4-(4-methylphenoxy)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(C)=CC=C1OC1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=NC(OC=3C=CC(F)=CC=3)=CC=2)CC1 BNYMQAJOSJXUFB-UHFFFAOYSA-N 0.000 description 1
- GMARCTCAIUDFNX-UHFFFAOYSA-N n-[6-(4-fluorophenoxy)pyridin-3-yl]-5-[4-(4-morpholin-4-ylbenzoyl)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1OC(N=C1)=CC=C1NC(=O)C1=CC=C(C(=O)N2CCC(CC2)C(=O)C=2C=CC(=CC=2)N2CCOCC2)C=N1 GMARCTCAIUDFNX-UHFFFAOYSA-N 0.000 description 1
- STPZXMKMNKFXAI-UHFFFAOYSA-N n-[6-(4-fluorophenoxy)pyridin-3-yl]-5-[4-(4-pyrrolidin-1-ylbenzoyl)piperidine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1OC(N=C1)=CC=C1NC(=O)C1=CC=C(C(=O)N2CCC(CC2)C(=O)C=2C=CC(=CC=2)N2CCCC2)C=N1 STPZXMKMNKFXAI-UHFFFAOYSA-N 0.000 description 1
- XOCNQFFZQFEWHW-UHFFFAOYSA-N n-[6-(4-fluorophenoxy)pyridin-3-yl]-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NC=2C=NC(OC=3C=CC(F)=CC=3)=CC=2)CC1 XOCNQFFZQFEWHW-UHFFFAOYSA-N 0.000 description 1
- FIRJMSDQQVUXBK-UHFFFAOYSA-N n-[6-(4-fluorophenoxy)pyridin-3-yl]-5-[4-[4-(trifluoromethyl)phenoxy]piperidine-1-carbonyl]pyrazine-2-carboxamide Chemical compound C1=CC(F)=CC=C1OC(N=C1)=CC=C1NC(=O)C1=CN=C(C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)C(F)(F)F)C=N1 FIRJMSDQQVUXBK-UHFFFAOYSA-N 0.000 description 1
- AECCUDKFJGLGKU-UHFFFAOYSA-N n-[6-(4-fluorophenoxy)pyridin-3-yl]-6-[4-(4-pyrrolidin-1-ylbenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(F)=CC=C1OC(N=C1)=CC=C1NC(=O)C1=CC=C(C(=O)N2CCC(CC2)C(=O)C=2C=CC(=CC=2)N2CCCC2)N=C1 AECCUDKFJGLGKU-UHFFFAOYSA-N 0.000 description 1
- HOYLOGISDOAXOM-UHFFFAOYSA-N n-[6-(4-fluorophenoxy)pyridin-3-yl]-6-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC=2C=NC(OC=3C=CC(F)=CC=3)=CC=2)CC1 HOYLOGISDOAXOM-UHFFFAOYSA-N 0.000 description 1
- CSSYEVQJDFHNJP-UHFFFAOYSA-N n-[6-(4-fluorophenoxy)pyridin-3-yl]-6-[4-[4-(4-methylpiperazin-1-yl)benzoyl]piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1CN(C)CCN1C1=CC=C(C(=O)C2CCN(CC2)C(=O)C=2N=CC(=CC=2)C(=O)NC=2C=NC(OC=3C=CC(F)=CC=3)=CC=2)C=C1 CSSYEVQJDFHNJP-UHFFFAOYSA-N 0.000 description 1
- BPLWMEIZMICBAU-UHFFFAOYSA-N n-[6-(4-fluorophenoxy)pyridin-3-yl]-6-[4-[4-(pentafluoro-$l^{6}-sulfanyl)phenoxy]piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(F)=CC=C1OC(N=C1)=CC=C1NC(=O)C1=CC=C(C(=O)N2CCC(CC2)OC=2C=CC(=CC=2)S(F)(F)(F)(F)F)N=C1 BPLWMEIZMICBAU-UHFFFAOYSA-N 0.000 description 1
- HSERFCLBNQCVPF-UHFFFAOYSA-N n-[6-(4-fluorophenyl)sulfonylpyridin-3-yl]-6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC=2C=NC(=CC=2)S(=O)(=O)C=2C=CC(F)=CC=2)CC1 HSERFCLBNQCVPF-UHFFFAOYSA-N 0.000 description 1
- HIHGKUXVUVLGOQ-UHFFFAOYSA-N n-[6-[4-(dimethylcarbamoyl)phenoxy]pyridin-3-yl]-6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]pyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(=O)C1CCN(C(=O)C=2N=CC(=CC=2)C(=O)NC=2C=NC(OC=3C=CC(=CC=3)C(=O)N(C)C)=CC=2)CC1 HIHGKUXVUVLGOQ-UHFFFAOYSA-N 0.000 description 1
- LYNNCHNXFHBVFJ-UHFFFAOYSA-N n-benzyl-5-(4-benzylpiperazine-1-carbonyl)pyridine-2-carboxamide Chemical compound C=1C=C(C(=O)N2CCN(CC=3C=CC=CC=3)CC2)C=NC=1C(=O)NCC1=CC=CC=C1 LYNNCHNXFHBVFJ-UHFFFAOYSA-N 0.000 description 1
- SFBUXGKMWDVQSW-UHFFFAOYSA-N n-benzyl-5-[4-[(4-fluorophenyl)methyl]piperazine-1-carbonyl]pyridine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=NC(=CC=2)C(=O)NCC=2C=CC=CC=2)CC1 SFBUXGKMWDVQSW-UHFFFAOYSA-N 0.000 description 1
- 230000009826 neoplastic cell growth Effects 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000000651 prodrug Substances 0.000 description 1
- 229940002612 prodrug Drugs 0.000 description 1
- IPEHBUMCGVEMRF-UHFFFAOYSA-N pyrazinecarboxamide Chemical compound NC(=O)C1=CN=CC=N1 IPEHBUMCGVEMRF-UHFFFAOYSA-N 0.000 description 1
- KHQXBNWTAKPRMR-UHFFFAOYSA-N pyridazine-3,6-dicarboxamide Chemical compound NC(=O)C1=CC=C(C(N)=O)N=N1 KHQXBNWTAKPRMR-UHFFFAOYSA-N 0.000 description 1
- LEIAZUKOBVWTEH-UHFFFAOYSA-N pyridine-2,5-dicarboxamide Chemical compound NC(=O)C1=CC=C(C(N)=O)N=C1 LEIAZUKOBVWTEH-UHFFFAOYSA-N 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 208000020431 spinal cord injury Diseases 0.000 description 1
- 125000003107 substituted aryl group Chemical group 0.000 description 1
- 125000005346 substituted cycloalkyl group Chemical group 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36892810P | 2010-07-29 | 2010-07-29 | |
| US61/368,928 | 2010-07-29 | ||
| PCT/US2011/046019 WO2012016217A1 (en) | 2010-07-29 | 2011-07-29 | Ampk-activating heterocyclic compounds and methods for using the same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013532692A JP2013532692A (ja) | 2013-08-19 |
| JP2013532692A5 true JP2013532692A5 (enExample) | 2014-09-04 |
| JP5889895B2 JP5889895B2 (ja) | 2016-03-22 |
Family
ID=44504240
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013522013A Expired - Fee Related JP5889895B2 (ja) | 2010-07-29 | 2011-07-29 | Ampk活性化複素環化合物およびその使用方法 |
Country Status (24)
| Country | Link |
|---|---|
| US (8) | US8791136B2 (enExample) |
| EP (1) | EP2598483B1 (enExample) |
| JP (1) | JP5889895B2 (enExample) |
| KR (1) | KR101764952B1 (enExample) |
| CN (1) | CN103201267B (enExample) |
| AU (1) | AU2011283684B2 (enExample) |
| BR (1) | BR112013002112B1 (enExample) |
| CA (1) | CA2806341C (enExample) |
| CL (1) | CL2013000261A1 (enExample) |
| DK (1) | DK2598483T3 (enExample) |
| EA (1) | EA025611B1 (enExample) |
| ES (1) | ES2823350T3 (enExample) |
| HU (1) | HUE052110T2 (enExample) |
| IL (1) | IL223856A (enExample) |
| MX (1) | MX338707B (enExample) |
| MY (1) | MY165584A (enExample) |
| NZ (1) | NZ605692A (enExample) |
| PE (1) | PE20130774A1 (enExample) |
| PL (1) | PL2598483T3 (enExample) |
| PT (1) | PT2598483T (enExample) |
| SG (1) | SG186850A1 (enExample) |
| UA (1) | UA112061C2 (enExample) |
| WO (1) | WO2012016217A1 (enExample) |
| ZA (2) | ZA201300374B (enExample) |
Families Citing this family (96)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3205644A1 (en) | 2005-12-29 | 2017-08-16 | Celtaxsys Inc. | Diamine derivatives as inhibitors of leukotriene a4 hydrolase |
| ES2823350T3 (es) * | 2010-07-29 | 2021-05-06 | Rigel Pharmaceuticals Inc | Compuestos heterocíclicos que activan AMPK y métodos de uso de los mismos |
| SG2014010417A (en) | 2011-10-07 | 2014-06-27 | Takeda Pharmaceutical | 1 - arylcarbonyl - 4 - oxy - piperidine compounds useful for the treatment of neurodegenerative diseases |
| US9409884B2 (en) | 2012-02-01 | 2016-08-09 | Rigel Pharmaceuticals, Inc. | 5- or 6-substituted benzofuran-2-carboxamide compounds and methods for using them |
| US8889730B2 (en) | 2012-04-10 | 2014-11-18 | Pfizer Inc. | Indole and indazole compounds that activate AMPK |
| US9126950B2 (en) | 2012-12-21 | 2015-09-08 | Celgene Avilomics Research, Inc. | Heteroaryl compounds and uses thereof |
| ES2649156T3 (es) | 2013-01-14 | 2018-01-10 | Incyte Holdings Corporation | Compuestos bicíclicos de carboxamida aromática útiles como inhibidores de quinasas Pim |
| CA2897333C (en) | 2013-01-15 | 2021-07-06 | Incyte Corporation | Thiazolecarboxamides and pyridinecarboxamide compounds useful as pim kinase inhibitors |
| TWI647227B (zh) | 2013-02-28 | 2019-01-11 | 日商安斯泰來製藥股份有限公司 | 2-醯胺噻唑衍生物或其鹽 |
| WO2014164658A1 (en) | 2013-03-12 | 2014-10-09 | Celtaxsys, Inc. | Methods of inhibiting leukotriene a4 hydrolase |
| MY191366A (en) | 2013-03-13 | 2022-06-20 | Forma Therapeutics Inc | Novel compounds and compositions for inhibition of fasn |
| EP2968264A4 (en) | 2013-03-14 | 2016-11-02 | Celtaxsys Inc | INHIBITORS OF LEUCOTRIENE A4 HYDROLASE |
| CA2906086A1 (en) | 2013-03-14 | 2014-09-25 | Celtaxsys, Inc. | Inhibitors of leukotriene a4 hydrolase |
| CA2906084A1 (en) | 2013-03-14 | 2014-09-25 | Celtaxsys, Inc. | Inhibitors of leukotriene a4 hydrolase |
| CA2905242C (en) | 2013-03-15 | 2016-11-29 | Pfizer Inc. | Indole compounds that activate ampk |
| BR112015030248A2 (pt) * | 2013-06-10 | 2017-07-25 | Astellas Pharma Inc | composto de amida heterocíclica aromática contendo nitrogênio bicíclico |
| US9695154B2 (en) | 2013-07-02 | 2017-07-04 | Millennium Pharmaceuticals, Inc. | Heteroaryl inhibitors of sumo activating enzyme |
| CR20160135A (es) | 2013-08-23 | 2016-08-05 | Incyte Corp | Compuestos de carboxamida de furo y tienopiridina útiles como inhibidores de cinasas pim |
| WO2015048547A2 (en) | 2013-09-26 | 2015-04-02 | Rigel Pharmaceuticals, Inc. | Methods for using and biomarkers for ampk-activating compounds |
| US20160214967A1 (en) * | 2013-09-30 | 2016-07-28 | The University Of Tokyo | Activator of adiponectin receptor |
| AU2014338549B2 (en) | 2013-10-25 | 2017-05-25 | Novartis Ag | Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors |
| US9415049B2 (en) | 2013-12-20 | 2016-08-16 | Celgene Avilomics Research, Inc. | Heteroaryl compounds and uses thereof |
| JO3517B1 (ar) | 2014-01-17 | 2020-07-05 | Novartis Ag | ان-ازاسبيرو الكان حلقي كبديل مركبات اريل-ان مغايرة وتركيبات لتثبيط نشاط shp2 |
| EP3094627B1 (en) | 2014-01-17 | 2018-08-22 | Novartis AG | 1-pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine derivatives and and compositions thereof for inhibiting the activity of shp2 |
| EP3094629B1 (en) | 2014-01-17 | 2018-08-22 | Novartis AG | 1-(triazin-3-yl/pyridazin-3-yl)-piper(-azine)idine derivatives and compositions thereof for inhibiting the activity of shp2 |
| SG10201900536TA (en) * | 2014-03-06 | 2019-02-27 | Shanghai Haiyan Pharmaceutical Tech Co Ltd | Piperidine derivatives as orexin receptor antagonist |
| MX370140B (es) | 2014-06-06 | 2019-12-03 | Astellas Pharma Inc | Derivado de 2-acilaminotiazol o sal del mismo. |
| PT3164130T (pt) | 2014-07-01 | 2019-11-18 | Millennium Pharm Inc | Compostos de heteroaril úteis como inibidores de enzima ativadora de sumo |
| WO2016010897A1 (en) | 2014-07-14 | 2016-01-21 | Incyte Corporation | Bicyclic heteroaromatic carboxamide compounds useful as pim kinase inhibitors |
| US9580418B2 (en) | 2014-07-14 | 2017-02-28 | Incyte Corporation | Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors |
| MX2017002500A (es) * | 2014-08-26 | 2017-05-23 | Astellas Pharma Inc | Derivado de 2-aminotiazol o sal del mismo. |
| ES2756748T3 (es) | 2014-10-03 | 2020-04-27 | Novartis Ag | Uso de derivados de piridilo bicíclicos de anillo fusionado como inhibidores de fgfr4 |
| CA2957868C (en) | 2014-10-10 | 2023-02-28 | Pulmocide Limited | Novel 5,6-dihydro-4h-benzo[b]thieno-[2,3-d]azepine derivative |
| RS61013B1 (sr) | 2014-10-24 | 2020-11-30 | Landos Biopharma Inc | Terapeutski preparati zasnovani na lantionin sintetazi c- sličnom proteinu-2 |
| US10160772B2 (en) | 2014-12-18 | 2018-12-25 | Pulmocide Limited | 5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivatives |
| US9802917B2 (en) | 2015-03-25 | 2017-10-31 | Novartis Ag | Particles of N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((4-methyl-2-oxopiperazin-1-yl)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide |
| US9540347B2 (en) | 2015-05-29 | 2017-01-10 | Incyte Corporation | Pyridineamine compounds useful as Pim kinase inhibitors |
| WO2016203404A1 (en) | 2015-06-19 | 2016-12-22 | Novartis Ag | Compounds and compositions for inhibiting the activity of shp2 |
| US10308660B2 (en) | 2015-06-19 | 2019-06-04 | Novartis Ag | Compounds and compositions for inhibiting the activity of SHP2 |
| EP3310774B1 (en) | 2015-06-19 | 2020-04-29 | Novartis AG | Compounds and compositions for inhibiting the activity of shp2 |
| TWI734699B (zh) | 2015-09-09 | 2021-08-01 | 美商英塞特公司 | Pim激酶抑制劑之鹽 |
| TW201718546A (zh) | 2015-10-02 | 2017-06-01 | 英塞特公司 | 適用作pim激酶抑制劑之雜環化合物 |
| PL3365334T3 (pl) | 2015-10-21 | 2024-11-25 | Otsuka Pharmaceutical Co., Ltd. | Związki benzolaktamu jako inhibitory kinazy białkowej |
| TWI739783B (zh) | 2016-01-22 | 2021-09-21 | 比利時商健生藥品公司 | 作為nik抑制劑的新穎的經取代氰基吲哚啉衍生物 |
| US11001569B2 (en) | 2016-01-22 | 2021-05-11 | Janssen Pharmaceutica Nv | 6-membered heteroaromatic substituted cyanoindoline derivatives as NIK inhibitors |
| HUE057838T2 (hu) | 2016-06-07 | 2022-06-28 | Jacobio Pharmaceuticals Co Ltd | SHP2 inhibitorokként hasznos új heterociklusos származékok |
| RU2744988C2 (ru) | 2016-06-14 | 2021-03-17 | Новартис Аг | Соединения и композиции для подавления активности shp2 |
| CN109641882B (zh) | 2016-06-30 | 2022-10-28 | 杨森制药有限公司 | 作为nik抑制剂的杂芳族衍生物 |
| KR102587619B1 (ko) | 2016-06-30 | 2023-10-11 | 잔센파마슈티카엔.브이. | Nik 억제제로서의 시아노인돌린 유도체 |
| EP3484876A1 (en) | 2016-07-14 | 2019-05-22 | Pfizer Inc | Novel pyrimidine carboxamides as inhibitors of vanin-1 enzyme |
| CN117777121A (zh) | 2016-10-24 | 2024-03-29 | 詹森药业有限公司 | 化合物及其用途 |
| EA201991650A1 (ru) | 2017-01-06 | 2020-01-20 | Юманити Терапьютикс, Инк. | Способы лечения неврологических расстройств |
| ES2964956T3 (es) | 2017-01-10 | 2024-04-10 | Novartis Ag | Combinación farmacéutica que comprende un inhibidor de ALK y un inhibidor de SHP2 |
| MX2022000938A (es) * | 2017-03-15 | 2022-12-14 | Lunella Biotech Inc | Mitorriboscinas: compuestos terapeuticos basados en mitocondrias que fijan como objetivo celulas cancerosas, bacterias y levaduras patogenas. |
| TWI664175B (zh) | 2017-03-23 | 2019-07-01 | 大陸商北京加科思新藥研發有限公司 | 用於作為shp2抑制劑之新穎雜環衍生物 |
| GB201706327D0 (en) | 2017-04-20 | 2017-06-07 | Otsuka Pharma Co Ltd | A pharmaceutical compound |
| JOP20190245A1 (ar) | 2017-04-20 | 2019-10-15 | Novartis Ag | أنظمة توصيل إطلاق مستدام تتضمن روابط بلا أثر لنقطة الربط |
| MY201938A (en) | 2017-08-04 | 2024-03-25 | Skyhawk Therapeutics Inc | Methods and compositions for modulating splicing |
| KR102717600B1 (ko) | 2017-10-06 | 2024-10-15 | 포르마 세라퓨틱스 인크. | 유비퀴틴 특이적 펩티다제 30의 억제 |
| WO2019084157A1 (en) | 2017-10-24 | 2019-05-02 | Yumanity Therapeutics, Inc. | COMPOUNDS AND USES THEREOF |
| MX387232B (es) | 2017-10-27 | 2025-03-18 | Boehringer Ingelheim Int | Derivados de piridincarbonilo y usos terapéuticos de los mismos como inhibidores de trpc6. |
| WO2019113487A1 (en) | 2017-12-08 | 2019-06-13 | Incyte Corporation | Low dose combination therapy for treatment of myeloproliferative neoplasms |
| AU2019220746A1 (en) | 2018-02-15 | 2020-08-27 | Nuvation Bio Inc. | Heterocyclic compounds as kinase inhibitors |
| AU2019238326B2 (en) | 2018-03-23 | 2025-03-06 | Janssen Pharmaceutica Nv | Compounds and uses thereof |
| CN112513036B (zh) | 2018-05-17 | 2024-05-24 | 福马治疗有限公司 | 用作泛素特异性肽酶30抑制剂的稠合双环化合物 |
| ES3014615T3 (en) | 2018-05-31 | 2025-04-23 | Celltaxis Llc | Method of reducing pulmonary exacerbations in respiratory disease patients |
| US12030875B2 (en) | 2018-09-07 | 2024-07-09 | PIC Therapeutics, Inc. | EIF4E inhibitors and uses thereof |
| CA3113234A1 (en) | 2018-09-18 | 2020-03-26 | Nikang Therapeutics, Inc. | Tri-substituted heteroaryl derivatives as src homology-2 phosphatase inhibitors |
| CN112839935A (zh) | 2018-09-26 | 2021-05-25 | 北京加科思新药研发有限公司 | 可用作shp2抑制剂的新型杂环衍生物 |
| AR116566A1 (es) | 2018-10-03 | 2021-05-19 | Novartis Ag | Administración sostenida de polipéptidos similares a la angiopoyetina 3 |
| ES2945834T3 (es) | 2018-10-05 | 2023-07-07 | Forma Therapeutics Inc | Pirrolinas fusionadas que actúan como inhibidores de la proteasa 30 específica de ubiquitina (USP30) |
| TWI767148B (zh) | 2018-10-10 | 2022-06-11 | 美商弗瑪治療公司 | 抑制脂肪酸合成酶(fasn) |
| US10793554B2 (en) | 2018-10-29 | 2020-10-06 | Forma Therapeutics, Inc. | Solid forms of 4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl)piperazin-1-yl)(1-hydroxycyclopropyl)methanone |
| CA3121202A1 (en) | 2018-11-30 | 2020-06-04 | Nuvation Bio Inc. | Pyrrole and pyrazole compounds and methods of use thereof |
| MX2021007425A (es) * | 2018-12-26 | 2021-08-05 | Raqualia Pharma Inc | Derivados heterociclicos como bloqueadores de nav1.7 y nav1.8. |
| JP7742775B2 (ja) | 2019-01-24 | 2025-09-22 | ヤンセン ファーマシューティカ エヌ.ベー. | 化合物及びその使用 |
| CN114007613A (zh) | 2019-02-05 | 2022-02-01 | 斯基霍克疗法公司 | 用于调节剪接的方法和组合物 |
| JP7603595B2 (ja) | 2019-02-06 | 2024-12-20 | スカイホーク・セラピューティクス・インコーポレーテッド | スプライシングを調節するための方法および組成物 |
| CA3138973A1 (en) | 2019-05-05 | 2020-11-12 | Qilu Regor Therapeutics Inc. | Cdk inhibitors |
| EA202192047A1 (ru) | 2019-11-13 | 2021-12-08 | Юманити Терапьютикс, Инк. | Соединения и их применение |
| JP7430852B2 (ja) | 2019-12-20 | 2024-02-14 | エヌイミューン バイオファーマ インコーポレイテッド | ランチオニンc様タンパク質2リガンド、それを用いて調製される細胞、およびそれを使用する療法 |
| WO2021138391A1 (en) | 2019-12-30 | 2021-07-08 | Tyra Biosciences, Inc. | Indazole compounds |
| US12234578B2 (en) | 2020-01-29 | 2025-02-25 | Wisconsin Alumni Research Foundation | Tannin composite fibers |
| IL296139A (en) | 2020-03-03 | 2022-11-01 | Pic Therapeutics Inc | Eif4e inhibitors and uses thereof |
| BR112022023359A2 (pt) | 2020-05-19 | 2023-04-18 | Kallyope Inc | Ativadores de ampk |
| JP2023531726A (ja) | 2020-06-26 | 2023-07-25 | キャリーオペ,インク. | Ampkアクチベーター |
| US12059408B2 (en) | 2020-08-13 | 2024-08-13 | Boehringer Ingelheim International Gmbh | Treatment of cognitive impairment associated with schizophrenia |
| WO2022072397A1 (en) | 2020-09-30 | 2022-04-07 | Bioverativ Therapeutics Inc. | Ampk activators and methods of use thereof |
| WO2022078927A1 (en) | 2020-10-13 | 2022-04-21 | Boehringer Ingelheim International Gmbh | Process of reworking |
| CA3205986A1 (en) | 2020-12-30 | 2022-07-07 | Tyra Biosciences, Inc. | Indazole compounds as kinase inhibitors |
| AU2022334296A1 (en) | 2021-08-25 | 2024-03-07 | PIC Therapeutics, Inc. | Eif4e inhibitors and uses thereof |
| WO2023028238A1 (en) | 2021-08-25 | 2023-03-02 | PIC Therapeutics, Inc. | Eif4e inhibitors and uses thereof |
| WO2023107705A1 (en) | 2021-12-10 | 2023-06-15 | Incyte Corporation | Bicyclic amines as cdk12 inhibitors |
| WO2024006297A1 (en) * | 2022-06-28 | 2024-01-04 | Modulation Therapeutics, Inc. | Scd1 inhibitors for treating liver disease |
| WO2025018978A1 (en) * | 2023-07-14 | 2025-01-23 | Modulation Therapeutics, Inc. | Scd1 inhibitors for treating hematolymphoid neoplasms |
| CN119039234A (zh) * | 2024-08-19 | 2024-11-29 | 中国药科大学 | 一种哒嗪酰胺类化合物及其制备方法与应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR045999A1 (es) * | 2003-07-18 | 2005-11-23 | Glaxo Group Ltd | Compuesto de eter de piperidina, su uso para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para prepararlo |
| CA2551037A1 (en) * | 2003-09-22 | 2005-03-31 | Banyu Pharmaceutical Co., Ltd. | Novel piperidine derivative |
| US7196100B2 (en) | 2003-12-12 | 2007-03-27 | Eli Lilly And Company | Opioid receptor antagonists |
| WO2007098086A2 (en) | 2006-02-17 | 2007-08-30 | Avalon Pharmaceuticals | Hydroxypiperidine derivatives and uses thereof |
| ATE507205T1 (de) * | 2006-12-11 | 2011-05-15 | Genetics Co Inc | Aromatische 1,4-di-carboxylamide und deren verwendung |
| ES2627221T3 (es) | 2006-12-28 | 2017-07-27 | Rigel Pharmaceuticals, Inc. | Compuestos de heterocicloalquiloxibenzamida N-sustituidos y métodos de uso |
| EP2190836B1 (en) * | 2007-08-22 | 2011-08-17 | Irm Llc | 2-heteroarylamino-pyrimidine derivatives as kinase inhibitors |
| ES2552733T3 (es) * | 2007-11-16 | 2015-12-01 | Rigel Pharmaceuticals, Inc. | Compuestos de carboxamida, sulfonamida y amina para trastornos metabólicos |
| WO2009076631A1 (en) * | 2007-12-12 | 2009-06-18 | Rigel Pharmaceuticals, Inc. | Carboxamide, sulfonamide and amine compounds for metabolic disorders |
| EP2276761B1 (en) * | 2008-04-23 | 2015-07-29 | Rigel Pharmaceuticals, Inc. | Carboxamide compounds for the treatment of metabolic disorders |
| JP5658688B2 (ja) * | 2009-01-28 | 2015-01-28 | ライジェル ファーマシューティカルズ, インコーポレイテッド | カルボキサミド化合物およびその使用方法 |
| SG175355A1 (en) * | 2009-04-27 | 2011-12-29 | Elan Pharm Inc | Pyridinone antagonists of alpha-4 integrins |
| JP2012526097A (ja) | 2009-05-08 | 2012-10-25 | ファイザー・インク | Gpr119調節因子 |
| ES2823350T3 (es) | 2010-07-29 | 2021-05-06 | Rigel Pharmaceuticals Inc | Compuestos heterocíclicos que activan AMPK y métodos de uso de los mismos |
| US9409884B2 (en) * | 2012-02-01 | 2016-08-09 | Rigel Pharmaceuticals, Inc. | 5- or 6-substituted benzofuran-2-carboxamide compounds and methods for using them |
-
2011
- 2011-07-29 ES ES11746709T patent/ES2823350T3/es active Active
- 2011-07-29 SG SG2012095964A patent/SG186850A1/en unknown
- 2011-07-29 PL PL11746709T patent/PL2598483T3/pl unknown
- 2011-07-29 JP JP2013522013A patent/JP5889895B2/ja not_active Expired - Fee Related
- 2011-07-29 WO PCT/US2011/046019 patent/WO2012016217A1/en not_active Ceased
- 2011-07-29 AU AU2011283684A patent/AU2011283684B2/en not_active Ceased
- 2011-07-29 NZ NZ605692A patent/NZ605692A/en not_active IP Right Cessation
- 2011-07-29 BR BR112013002112-8A patent/BR112013002112B1/pt not_active IP Right Cessation
- 2011-07-29 US US13/194,810 patent/US8791136B2/en active Active
- 2011-07-29 HU HUE11746709A patent/HUE052110T2/hu unknown
- 2011-07-29 MY MYPI2013000077A patent/MY165584A/en unknown
- 2011-07-29 PE PE2013000118A patent/PE20130774A1/es active IP Right Grant
- 2011-07-29 DK DK11746709.2T patent/DK2598483T3/da active
- 2011-07-29 EA EA201390184A patent/EA025611B1/ru not_active IP Right Cessation
- 2011-07-29 MX MX2013000575A patent/MX338707B/es active IP Right Grant
- 2011-07-29 CN CN201180047484.XA patent/CN103201267B/zh not_active Expired - Fee Related
- 2011-07-29 EP EP11746709.2A patent/EP2598483B1/en active Active
- 2011-07-29 UA UAA201302459A patent/UA112061C2/uk unknown
- 2011-07-29 KR KR1020137005054A patent/KR101764952B1/ko not_active Expired - Fee Related
- 2011-07-29 CA CA2806341A patent/CA2806341C/en active Active
- 2011-07-29 PT PT117467092T patent/PT2598483T/pt unknown
-
2012
- 2012-12-25 IL IL223856A patent/IL223856A/en active IP Right Grant
-
2013
- 2013-01-15 ZA ZA2013/00374A patent/ZA201300374B/en unknown
- 2013-01-28 CL CL2013000261A patent/CL2013000261A1/es unknown
- 2013-03-13 US US13/800,986 patent/US8809370B2/en active Active
- 2013-03-13 US US13/801,030 patent/US8987303B2/en active Active
- 2013-03-13 US US13/801,064 patent/US8980921B2/en active Active
-
2014
- 2014-03-13 ZA ZA2014/01833A patent/ZA201401833B/en unknown
- 2014-07-08 US US14/325,766 patent/US9266856B2/en not_active Expired - Fee Related
-
2016
- 2016-01-12 US US14/993,936 patent/US9663496B2/en not_active Expired - Fee Related
-
2017
- 2017-05-23 US US15/603,023 patent/US10377742B2/en active Active
-
2019
- 2019-06-25 US US16/451,613 patent/US10941134B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013532692A5 (enExample) | ||
| CN117242067B (zh) | 作为glp1r激动剂的新型芳醚取代杂环类化合物 | |
| JP5889895B2 (ja) | Ampk活性化複素環化合物およびその使用方法 | |
| JP5432718B2 (ja) | ピロール化合物 | |
| EP3101015B1 (en) | Heterocyclic sulfonamide derivative and medicine comprising same | |
| US20130029962A1 (en) | Substituted Heteroaromatic Pyrazole-Containing Carboxamide and Urea Compounds as Vanilloid Receptor Ligands | |
| JP2011506480A5 (enExample) | ||
| JP2011503210A5 (enExample) | ||
| JP2010514788A5 (enExample) | ||
| JP2008522952A (ja) | 酸分泌抑制薬としての1−ヘテロシクリルスルホニル、2−アミノメチル、5−(ヘテロ−)アリール置換1−h−ピロール誘導体 | |
| US20130029961A1 (en) | Substituted Heterocyclic Aza Compounds | |
| JP2008516902A5 (enExample) | ||
| JP2008509955A5 (enExample) | ||
| JP2012516349A5 (enExample) | ||
| EP2448584B1 (en) | Substituted 4-hydroxypyrimidine-5-carboxamides | |
| CN112105356A (zh) | 作为转运蛋白的调节剂的双环烯酮羧酸酯类化合物及其应用 | |
| CN103153957B (zh) | N-吡啶-3-基或n-吡嗪-2-基甲酰胺类 | |
| WO2025222008A1 (en) | Glucagon receptor agonists and their use as therapies | |
| JP2007516290A5 (enExample) | ||
| RU2376295C2 (ru) | Производные пиримидинона и фармацевтическая композиция на их основе, обладающая свойствами ингибитора нейтрофильной эластазы человека |